Cell Surface RNA: From Foundational Biology to Therapeutic Innovation

Abstract

This article synthesizes the rapidly advancing field of cell surface RNA localization, a paradigm-shifting concept where nuclear-encoded RNAs are stably displayed on the extracellular face of the plasma membrane. We explore the foundational principles of membrane-associated extracellular RNAs (maxRNAs), detailing their mechanistic basis and biological roles in cell-cell and cell-environment interactions. The review provides a critical analysis of cutting-edge methodologies for maxRNA profiling and validation, including Surface-seq, RNA proximity labeling, and surface-specific FISH. We further address key technical challenges and comparative analyses, concluding with an examination of the immense translational potential of cell surface RNAs as biomarkers and therapeutic targets for drug development professionals.

Redefining the Cell Surface: The Discovery and Significance of Membrane-Associated Extracellular RNAs (maxRNAs)

The classical paradigm of RNA compartmentalization holds that nuclear-encoded RNAs (ngRNAs) are largely restricted to the intracellular space, with any extracellular presence typically attributed to vesicle encapsulation or cell death. Recent research challenges this view by identifying a stable population of membrane-associated extracellular RNAs (maxRNAs) on the cell surface of intact cells. This technical guide explores the discovery, validation, and functional significance of maxRNAs, introducing specialized methodologies for their study and discussing their implications for cell-cell communication and therapeutic development. The emergence of maxRNA biology necessitates a fundamental reconsideration of RNA localization and function in eukaryotic cells.

The maxRNA Paradigm: Redefining Cellular RNA Geography

Historical Context and Conventional RNA Localization Dogma

Traditional cell biology has established a clear compartmentalization of biomolecules: proteins, glycans, and lipids perform essential functions at the cell surface, while nucleic acids, particularly nuclear-encoded RNAs, remain intracellular constituents. According to classical models, any ngRNAs found outside the cell membrane were attributed to pathological states such as cell death and membrane damage, or to specific export mechanisms via extracellular vesicles [1]. This understanding is being fundamentally reconsidered with the discovery of maxRNAs—nuclear-encoded RNAs stably attached to the cell surface and exposed to the extracellular space under physiological conditions [1] [2].

The conceptual foundation for surface-localized RNAs initially emerged from bacterial studies, where non-coding RNAs were found to form ribonucleoprotein complexes with transmembrane proteins and incorporate into the cell membrane [1]. In human cells, preliminary evidence suggested that some ngRNAs could bind membrane lipids under physiological ionic conditions, and atomic force microscopy revealed that RNAs can coat artificial phospholipid membranes [1]. These early findings hinted at a potentially conserved biological phenomenon that contradicted established eukaryotic RNA localization paradigms.

Defining Characteristics of maxRNAs

MaxRNAs are formally defined as membrane-associated extracellular RNAs that meet three specific criteria [1]:

• Nuclear encoded: Transcribed from the nuclear genome unlike mitochondrial RNAs
• Stably membrane-associated: Firmly attached to the plasma membrane rather than weakly adsorbed
• Extracellularly exposed: Positioned on the outer cell surface, accessible to extracellular probes

This definition specifically excludes RNAs encapsulated within cellular or extracellular vesicles, and cell-free RNAs not stably attached to cell membranes [1]. The stable association with the plasma membrane distinguishes maxRNAs from artifacts of cell damage or dying cells, where RNA release occurs passively through compromised membrane integrity.

Methodological Innovations for maxRNA Research

The investigation of maxRNAs requires specialized techniques that can distinguish surface-exposed RNAs from intracellular RNAs while maintaining membrane integrity. Standard RNA detection methods typically involve membrane permeabilization, rendering them unsuitable for maxRNA studies.

Surface-seq: High-Throughput maxRNA Identification

Surface-seq represents a groundbreaking approach for the comprehensive identification and sequencing of maxRNAs. This nanotechnology-based method leverages membrane-coated nanoparticles (MCNPs) that preserve the native orientation of plasma membrane components [1].

Table: Surface-seq Technical Variations

Variation	Methodology	RNA Population Captured	Key Applications
Variation A	RNA extraction from assembled MCNPs followed by library construction	All membrane-associated RNAs (both sides)	Comprehensive maxRNA profiling
Variation B	Direct ligation of 3' RNA adaptor to outside-facing RNAs on MCNPs	Outside-facing membrane RNAs only	Specific identification of extracellularly exposed maxRNAs

The Surface-seq workflow involves [1]:

• Membrane purification: Isolation of plasma membranes from target cells
• MCNP assembly: Tight assembly of membranes around polymeric cores, maintaining inside-outside orientation
• RNA processing: Variation-specific RNA isolation and library construction
• High-throughput sequencing: Comprehensive RNA sequencing and bioinformatic analysis

Application of Surface-seq to EL4 cells identified 200-400 long non-coding RNAs (lncRNAs) across replicate libraries, with 82 lncRNAs consistently detected across all experiments, including Malat1, Neat1, and Snhg20 [1]. The reads were not uniformly distributed across transcripts but enriched at specific regions, suggesting potential functional domains or binding sites.

Surface-FISH: Validation of Surface Localization

Surface-FISH (RNA fluorescence in situ hybridization) provides orthogonal validation of maxRNA identification through direct visualization. This technique adapts conventional RNA-FISH by eliminating the membrane permeabilization step, thereby restricting signal exclusively to surface-exposed RNAs [1].

Protocol: Surface-FISH for maxRNA Validation [1]

• Probe design: Five quantum-dot-labeled oligonucleotide probes (40 nt each) targeting specific regions of candidate maxRNAs
• Hybridization: Incubation of live, intact cells with probe sets without permeabilization
• Control experiments: Parallel hybridization with mutant probes (6 central base pairs mutated) to establish specificity
• Signal detection: Imaging and quantification of surface foci using fluorescence microscopy
• Viability confirmation: Co-staining with transmission-through-dye (TTD) markers to verify membrane integrity

Application of Surface-FISH to EL4 cells confirmed the surface presence of Malat1 and Neat1 transcripts, with nearly all cells exhibiting 1-10 surface foci when probed with wild-type but not mutant probes (p < 0.0001) [1]. The combination with TTD microscopy demonstrated that these signals originated from cells with intact membranes, ruling out leakage from damaged cells.

In Situ Surface FISH (isFISH) with Imaging Flow Cytometry

For primary cell analysis, particularly with heterogeneous populations like peripheral blood mononuclear cells (PBMCs), researchers have developed isFISH coupled with imaging flow cytometry (IFC). This approach enables [1]:

• High-throughput quantification of maxRNA-positive cells
• Cell-type specificity determination through simultaneous surface marker detection
• Single-cell resolution of maxRNA expression patterns

In practice, isFISH employs a randomized library of fluorescence-labeled 20-mer oligonucleotides to probe for putative maxRNAs on PBMCs, followed by six-channel IFC analysis detecting brightfield, viability, nuclear staining, maxRNA signal, and cell surface markers (CD14, CD3ε, CD19) [1]. Appropriate controls include randomized 6-mer libraries, species-specific RNA probes, and fluorophore-only conditions.

Quantitative Profiling of maxRNAs: Composition and Specificity

Rigorous characterization of maxRNA populations reveals distinctive compositional features and cell-type-specific expression patterns that underscore their potential functional significance.

maxRNA Composition in Model Systems

Application of Surface-seq to EL4 cells demonstrated that maxRNAs are not random samples of the cellular transcriptome but represent specific RNA populations with distinctive features [1]:

Table: maxRNA Profiling in EL4 Cells

RNA Category	Detection in Surface-seq	Representative Transcripts	Notable Features
Long non-coding RNAs	200-400 lncRNAs across replicates	Malat1, Neat1, Snhg20	82 lncRNAs shared across all libraries
Outside-facing maxRNAs	17 lncRNAs enriched in Variation B	Malat1	Significantly enriched on extracellular surface (FDR < 0.05)
Spatial distribution	Non-uniform read distribution	Enriched at center of Malat1	Suggests specific domains may mediate surface association

The non-uniform distribution of Surface-seq reads across transcripts like Malat1, with particular enrichment around the center of the transcript, suggests that specific structural domains or sequence motifs may facilitate membrane association or surface presentation [1].

Cell-Type Specificity in Primary Human Cells

Analysis of primary human PBMCs reveals that maxRNA expression exhibits marked cell-type specificity, supporting their potential functional specialization rather than stochastic surface adsorption [1]:

• Overall frequency: 4.8% of total PBMCs exhibited isFISH signals, representing a 27-fold enrichment over control groups (p < 0.005)
• Monocyte enrichment: >10% of CD14+ monocytes were maxRNA-positive
• Lymphocyte presence: Approximately 3% of CD3ε+ T cells showed maxRNA signals
• Statistical significance: Cell-type differences were statistically significant (p < 0.005, t-test)

This cell-type-specific expression pattern follows the "guilt-by-association" principle, suggesting that maxRNAs likely contribute to specialized functions of the presenting cells [1]. The particular enrichment in monocytes implies potential roles in innate immunity or vascular interactions.

Functional Significance: maxRNAs in Cellular Adhesion

Beyond their mere presence on the cell surface, emerging evidence indicates that maxRNAs participate in specific cellular functions, particularly in mediating cell-cell interactions.

Functional Assessment via Antisense Oligonucleotides

To probe maxRNA function, researchers have employed extracellular application of antisense oligonucleotides (ASOs) targeting candidate maxRNAs. This approach tests whether specific disruption of surface RNA presentation affects cellular behavior while avoiding intracellular RNA interference mechanisms [1].

Experimental Protocol: Functional maxRNA Interference [1]

• Candidate prioritization: Selection of 11 candidate maxRNAs from monocyte Surface-seq data
• ASO design: Antisense oligos targeting FNDC3B and CTSS transcripts
• Extracellular application: Incubation of ASOs with intact monocytes without transfection agents
• Functional assay: Measurement of monocyte adhesion to vascular endothelial cells under static or flow conditions
• Quantification: Enumeration of adherent monocytes under various treatment conditions

This experimental paradigm demonstrated that extracellular application of ASOs targeting FNDC3B and CTSS maxRNAs significantly inhibited monocyte adhesion to vascular endothelial cells [1]. The functional effect of surface RNA disruption suggests that these maxRNAs play active roles in mediating cellular interactions rather than serving as passive surface decorations.

Implications for Cell-Cell and Cell-Environment Interactions

The inhibition of monocyte adhesion following maxRNA targeting suggests several mechanistic possibilities for maxRNA function [1]:

• Direct interaction with complementary RNAs on opposing cells
• Modulation of surface protein activity or presentation
• Stabilization of adhesion complexes through RNA-protein interactions
• Receptor-like signaling upon ligand binding

These findings collectively position maxRNAs as functional components of the cell surface, potentially expanding the molecular vocabulary for cell-cell and cell-environment interactions beyond the established protein-, glycan-, and lipid-centric mechanisms [1].

Conducting maxRNA research requires specialized reagents and computational resources designed specifically for surface RNA analysis and RNA biology more broadly.

Table: Essential Research Reagent Solutions for maxRNA Studies

Reagent/Resource	Function/Application	Key Features
Membrane-Coated Nanoparticles (MCNPs)	Plasma membrane purification and orientation preservation	Polymeric cores for stable membrane assembly; maintains inside-outside orientation
Quantum-Dot-Labeled Oligonucleotides	Surface-FISH probe design	40-nt probes with quantum dot fluorophores; mutant controls for specificity
Randomized Oligo Libraries	isFISH probing of heterogeneous maxRNA populations	20-mer fluorescence-labeled oligonucleotides; 6-mer controls for background assessment
Antisense Oligonucleotides (ASOs)	Functional perturbation of specific maxRNAs	Designed for extracellular application without transfection
RNA-KG Knowledge Graph	Contextualizing maxRNA findings within broader RNA biology	Integrates data from 60+ public databases; 673,825 nodes and 12,692,212 edges [3]
miRNATissueAtlas 2025	Reference for conventional RNA localization patterns	61,593 samples across 74 organs and 373 tissues; includes H. sapiens and M. musculus [4]

Visualizing maxRNA Research: Experimental Workflows and Conceptual Framework

The following diagrams illustrate key methodological approaches and conceptual models in maxRNA research, providing visual references for experimental design and data interpretation.

Surface-seq Methodology: maxRNA Identification

Surface-FISH Workflow: maxRNA Validation

Functional Analysis: maxRNA Perturbation

Future Directions and Therapeutic Implications

The emerging field of maxRNA biology presents numerous unanswered questions and promising research directions that intersect with drug development and therapeutic innovation.

Unresolved Questions in maxRNA Biology

Key outstanding questions include [1] [5]:

• Mechanisms of surface localization: How are specific RNAs selectively trafficked to and retained at the cell surface?
• Structural determinants: What RNA sequences, modifications, or structural features enable stable membrane association?
• Homeostatic regulation: How are maxRNA levels regulated in response to cellular states or environmental cues?
• Evolutionary conservation: To what extent are maxRNA mechanisms and functions conserved across eukaryotic species?

Therapeutic Potential and Diagnostic Applications

The functional demonstration that extracellular ASOs targeting maxRNAs can modulate cellular adhesion suggests several therapeutic avenues [1]:

• Inflammatory disease modulation: Targeting monocyte-endothelial adhesion in atherosclerosis or autoimmune conditions
• Cancer intervention: Disrupting circulating tumor cell adhesion and metastatic niche formation
• Diagnostic biomarkers: Utilizing cell surface RNA profiles for disease detection or immune monitoring
• Drug delivery: Leveraging maxRNA localization mechanisms for targeted therapeutic delivery

The established success of RNA-based therapeutics, including mRNA vaccines and RNA-targeting drugs, provides a robust foundation for developing maxRNA-focused therapeutic strategies [3]. The RNA-KG knowledge graph, integrating information from over 60 databases, offers a powerful resource for contextualizing maxRNA findings within the broader landscape of RNA biology and therapeutic development [3].

The discovery and characterization of maxRNAs fundamentally challenges classical views of RNA compartmentalization, revealing an expanded role for RNA in cell-surface biology and intercellular communication. Through specialized methodologies like Surface-seq and Surface-FISH, researchers can now systematically identify, validate, and functionally characterize these membrane-associated extracellular RNAs. The cell-type-specific expression and functional involvement in cellular adhesion processes position maxRNAs as potential therapeutic targets and diagnostic tools. As this emerging field progresses, maxRNA biology promises to reshape our understanding of cell surface composition and RNA functionality in health and disease.

The cell surface serves as the primary interface for interactions between a cell and its external environment, playing crucial roles in signal transduction, intercellular communication, and immune surveillance [6]. Traditionally, this landscape was considered to be composed predominantly of proteins, glycans, and lipids. However, a paradigm-shifting body of evidence now demonstrates that nuclear-encoded RNAs (ngRNAs) are also stably present on the extracellular surface of intact cells [1] [7]. This discovery challenges the long-held belief that ngRNAs are confined to the intracellular compartment and suggests a vastly expanded role for RNA in cellular communication. The validation of these membrane-associated extracellular RNAs (maxRNAs) and glycosylated RNAs (glycoRNAs) represents a fundamental advance in cell biology, with significant implications for understanding immune regulation, cancer biology, and therapeutic development [6] [8]. This technical guide synthesizes the key evidence, methodologies, and mechanistic insights validating the presence of nuclear-encoded RNA on the cell surface, providing researchers with a comprehensive framework for this emerging field.

Foundational Evidence and Key Validating Experiments

The initial discovery of cell surface RNAs required overcoming significant technical challenges, primarily the difficulty in distinguishing RNAs stably attached to the external membrane from intracellular RNA or RNA contained within extracellular vesicles. Through rigorous experimental approaches, multiple independent research groups have now confirmed the existence and functional significance of cell surface RNAs.

Surface-seq: Systematic Identification of maxRNAs

A groundbreaking advancement came from bioengineers at UC San Diego, who developed Surface-seq, a specialized nanotechnology for the specific detection of membrane-associated extracellular RNAs (maxRNAs) [1] [7]. This technique is based on a membrane-coating nanotechnology that preserves the native inside-outside orientation of the plasma membrane. The multi-step methodology is detailed below:

Table 1: Core Steps of the Surface-seq Protocol

Step	Process Description	Key Outcome
1. Membrane Extraction	Plasma membrane is purified from intact cells.	Preservation of native membrane topology with extracellular face outward.
2. Nanoparticle Assembly	Extracted membrane is assembled around polymeric cores to form membrane-coated nanoparticles (MCNPs).	Rigorous removal of intracellular contents while retaining membrane-associated molecules.
3. RNA Capture & Sequencing	RNAs on the MCNP exterior are captured and sequenced.	Selective identification of outside-facing, membrane-associated RNAs.

Application of Surface-seq to EL4 cells consistently identified specific long non-coding RNAs (lncRNAs) on the cell surface, including MALAT1 and NEAT1 [1]. Validation experiments confirmed these RNAs were not artifacts of membrane damage, as they remained detectable on cells with intact membranes verified by transmission-through-dye (TTD) microscopic analysis [1].

Independent Validation via Alternative Methodologies

Further confirmation emerged from independent research using different methodological approaches. One study utilized synthetic DNA G-quadruplex (G4) structures as probes to investigate cell surface RNA, finding that a significant amount of RNA, primarily fragments 20–100 nucleotides in length including microRNAs, is associated with the cell surface across various cell lines [9]. Another pivotal study reported that small non-coding RNAs can be modified by N-glycans, forming what are now termed glycoRNAs, which are present on the cell surface [6] [9]. These glycoRNAs were shown to be synthesized via the endoplasmic reticulum-Golgi pathway, a process dependent on the oligosaccharyltransferase (OST) complex, and have been identified as potential ligands for Siglec family immunoregulatory receptors [6].

Detailed Experimental Protocols for Detection and Validation

To equip researchers with practical tools for investigating cell surface RNA, this section details the primary protocols used in key studies. Mastery of these techniques is essential for generating validated data in this field.

Surface-FISH for Direct Visualization

Surface RNA Fluorescence In Situ Hybridization (Surface-FISH) was developed to visually confirm the presence of specific maxRNAs on the exterior of live cells without permeabilizing the membrane [1]. The protocol involves:

• Probe Design: A set of five quantum-dot-labeled oligonucleotide probes (each 40 nt) are designed to target specific regions of the candidate RNA (e.g., MALAT1).
• Hybridization: Live, intact cells are incubated with the probe set. A critical control uses probes with six centrally-located mutated bases (mut-Malat1) to confirm signal specificity.
• Image Acquisition & Analysis: Cells are imaged using fluorescence microscopy. Valid maxRNA signals appear as distinct foci on the cell surface. Researchers typically examine 20-30 single cells per probe-set, with signal counts compared to mutation-control probes using statistical tests like the Wilcoxon rank test [1].

Functional Probing with Antisense Oligonucleotides

Functional roles of maxRNAs can be investigated by applying antisense oligonucleotides (ASOs) to the extracellular environment of live cells [1]. This technique leverages the accessibility of surface RNAs for potential therapeutic targeting.

• Procedure: Fluorescence-labeled ASOs are hybridized to maxRNAs on the surface of primary human peripheral blood mononuclear cells (PBMCs).
• Detection & Sorting: The binding is analyzed via imaging flow cytometry (IFC), which can be combined with single-cell RNA sequencing to identify the specific maxRNA transcripts and the cell types presenting them.
• Functional Assay: The physiological role is tested by applying ASOs against specific maxRNAs (e.g., FNDC3B and CTSS) and assessing changes in cellular behavior, such as monocyte adhesion to vascular endothelial cells [1].

Analytical Framework and Data Interpretation

Accurate interpretation of cell surface RNA data requires a rigorous analytical framework to distinguish true surface localization from potential artifacts.

Critical Validation Controls

The following controls are essential for any study of cell surface RNA:

• Membrane Integrity Controls: Use dyes like transmission-through-dye (TTD) to confirm the plasma membrane is intact and impermeable to small molecules during experiments [1].
• Probe Specificity Controls: Include control probes with scrambled or mutated sequences to account for non-specific hybridization or background signal [1].
• Enzymatic Controls: Treat cells with extracellular RNase to remove surface-exposed RNA, confirming the localization of the signal. Conversely, use proteases to assess if RNA attachment is protein-mediated, as this can increase RNA accessibility in some cases [9].

Quantitative Profiling and Comparative Analysis

The table below synthesizes key characteristics of the major classes of cell surface RNAs identified to date, providing a comparative overview for researchers.

Table 2: Comparative Profile of Validated Cell Surface RNA Types

Feature	maxRNA	glycoRNA
Primary RNA Types	Long non-coding RNAs (e.g., MALAT1, NEAT1) [1]	Small non-coding RNAs (snRNAs, snoRNAs, miRNAs) [6]
Key Modification	Not specified	N-glycans rich in sialic acid and fucose [6]
Anchoring Mechanism	Not fully elucidated; potential lipid or protein mediation [1]	Association with glycosylation machinery; acp3U nucleotide as a potential anchor [6]
Validated Functions	Modulation of monocyte adhesion [1]	Immune recognition via Siglec receptors and P-selectin [6]

The Scientist's Toolkit: Essential Research Reagents

Research in this field relies on a specialized set of reagents and tools. The following table catalogues essential solutions for designing experiments on cell surface RNA.

Table 3: Key Research Reagent Solutions for Cell Surface RNA Studies

Research Reagent	Function/Application	Specific Examples
Membrane-coated Nanoparticles (MCNPs)	Isolate and preserve the native orientation of the cell membrane for Surface-seq.	Polymeric cores coated with purified plasma membrane [1] [7].
Quantum-dot-labeled FISH Probes	Visualize specific RNA molecules on the cell surface without permeabilization.	40-nt oligonucleotide probes targeting MALAT1 or NEAT1 [1].
Antisense Oligonucleotides (ASOs)	Functionally block or target surface RNAs for therapeutic investigation.	ASOs against FNDC3B and CTSS to inhibit monocyte adhesion [1].
Metabolic Labeling Agents	Tag newly synthesized RNA to track its trafficking to the cell surface.	5-ethynyl uridine (EU) for in vivo labeling [10].
Glycan-Binding Proteins	Probe for the presence and function of glycosylated RNAs (glycoRNAs).	Siglec-Fc chimeric proteins, P-selectin [6].
Specific Enzymes	Characterize the molecular environment of the surface RNA.	RNase A (removes surface RNA), Proteases (cleaves surface proteins) [9].
Dipotassium Glycyrrhizinate	Dipotassium Glycyrrhizinate | Research Compound
3-Methyl-4-phenyl-3-buten-2-one	3-Methyl-4-phenyl-3-buten-2-one, CAS:1901-26-4, MF:C11H12O, MW:160.21 g/mol	Chemical Reagent

Visualizing Experimental Workflows

The following diagram illustrates the core workflow for the Surface-seq technology, a foundational method for profiling maxRNAs.

The detection of glycoRNAs relies on different biochemical principles, primarily targeting the unique glycan modifications on the RNA, as shown in the workflow below.

The validation of nuclear-encoded RNA on the cell surface represents a fundamental expansion of our understanding of the molecular geography of the cell. Techniques like Surface-seq, Surface-FISH, and glycoRNA profiling have provided robust, multi-faceted evidence for this phenomenon. These surface RNAs are not random debris but functional molecules implicated in critical processes like immune cell adhesion and intercellular signaling [1] [11]. For researchers and drug development professionals, this new class of surface biomolecules opens a promising frontier. The external accessibility of maxRNAs and glycoRNAs makes them attractive targets for novel therapeutic strategies, including the use of ASOs, which are easier to develop than antibodies [7]. Future research will undoubtedly focus on elucidating the precise biogenesis and transport mechanisms of these RNAs, exploring their full functional repertoire in health and disease, and ultimately harnessing their potential for precision medicine and next-generation diagnostics.

The traditional paradigm of RNA as a solely intracellular molecule has been fundamentally challenged. Recent research has revealed a rich landscape of diverse RNA species, including long non-coding RNAs (lncRNAs), microRNAs (miRNAs), and mRNA fragments, on the extracellular surface of mammalian cells. This whitepaper synthesizes current understanding of cell surface RNA localization, biological functions, and experimental methodologies for their study. We highlight the metastasis-associated lung adenocarcinoma transcript 1 (Malat1) as a paradigm-shifting example of a nuclear lncRNA with regulated cytoplasmic and surface presence in neuronal cells. The discovery of surface RNAs opens new avenues for understanding cell signaling, immune recognition, and developing RNA-based diagnostic and therapeutic strategies. Technical advances in profiling and visualizing surface RNAs while maintaining membrane integrity are catalyzing this emerging field, with profound implications for cancer research, neuroscience, and immunology.

RNA localization has long been recognized as a fundamental mechanism for post-transcriptional gene regulation, enabling spatiotemporal control of the proteome at subcellular levels. The presence of specific mRNA populations in neuronal axons facilitates rapid adaptive responses to extracellular cues distant from the cell body [12]. Similarly, mitochondrial microRNAs (MitomiRs) regulate energy production and oxidative stress responses within organelles [13]. However, the recent discovery of RNAs positioned on the external surface of plasma membranes represents a revolutionary expansion of RNA functional territories.

This whitepaper examines the diverse RNA species detected on cell surfaces, focusing on the unexpected externalization of various RNA classes. We explore the mechanistic insights from studies of Malat1, a well-characterized nuclear lncRNA now known to traffic to cytoplasmic compartments and potentially to cell surfaces in specific contexts. We further detail the experimental toolkit enabling this emerging field, highlighting methodologies that preserve membrane integrity for authentic surface RNA profiling. The framework presented herein aims to equip researchers with the conceptual and technical foundation to advance our understanding of surface RNA biology and its therapeutic applications.

The Malat1 Paradigm: From Nuclear LncRNA to Regulated Localization

Malat1 represents a compelling case study of an RNA defying traditional classification. Historically defined as a nuclear lncRNA enriched in nuclear speckles and influencing splicing and chromatin organization, Malat1 is now understood to undergo regulated subcellular redistribution under specific physiological conditions.

Cytoplasmic Trafficking in Neurons

Recent research has demonstrated that during neuronal differentiation, a portion of Malat1 transcripts is exported to the cytoplasm, contrary to its predominantly nuclear localization in other cell types [14]. In developing cortical neurons, Malat1 redistributes from the nucleus to cytoplasmic puncta within both axons and dendrites. These puncta increase in number during neuronal maturation and colocalize with Staufen1 protein, a component of neuronal RNA granules formed by locally translated mRNAs [14]. Single-molecule RNA fluorescence in situ hybridization (smFISH) confirms Malat1's presence in neuronal processes, with a higher density observed in axons than dendrites and a decreasing gradient along the processes with increasing distance from the soma [14].

Functional Implications of Localized Malat1

The cytoplasmic localization of Malat1 enables non-canonical functions beyond its nuclear roles. Ribosome profiling in mouse cortical neurons identified ribosome footprints within Malat1's 5' region containing short open reading frames (micro-ORFs) [14]. The upstream-most reading frame (M1) produces a micropeptide whose expression is enhanced by synaptic stimulation with KCl, indicating activity-dependent translation [14]. This finding reclassifies Malat1 as a cytoplasmic coding RNA in the brain, modulating and being modulated by synaptic function. Depletion experiments using antisense oligonucleotides (ASOs) revealed that Malat1 affects the expression of pre- and postsynaptic proteins, influencing neuronal maturation and activity [14].

Table: Key Findings on Malat1 Localization and Function

Aspect	Traditional Understanding	New Paradigm
Primary Localization	Enriched in nuclear speckles across most cell types [15]	Portions exported to cytoplasm in differentiating neurons [14]
Subcellular Distribution	Exclusively nuclear	Localized in puncta within axons and dendrites; associates with Staufen1 [14]
Coding Potential	Classified as non-coding RNA	Contains micro-ORFs; produces a micropeptide regulated by synaptic activity [14]
Functional Role	Regulates splicing, chromatin organization, transcription [15]	Affects synaptic protein expression; modulates neuronal maturation and activity [14]

Landscape of Surface RNA Species

Beyond Malat1, a diverse repertoire of RNA species localizes to the extracellular surface of plasma membranes across various cell types. Advanced profiling techniques have revealed an unexpected abundance of noncoding RNAs on the surface of blood cells.

Documented Surface RNA Classes

Application of the AMOUR (A Method for Outer-membrane Unbiased RNA) profiling technology has identified a rich landscape of surface RNAs on human and murine blood cells. This includes Y-family RNAs, the spliceosomal snRNA U5, mitochondrial rRNA MTRNR2, mitochondrial tRNA MT-TA, VTRNA1-1, and the long noncoding RNA XIST [16]. Three-dimensional, nanometer-scale imaging has corroborated the surface localization of RNY5, MTRNR2, and XIST on live human umbilical cord blood mononuclear cells (hUCB-MNCs) [16].

Significance of Surface RNA Composition

The protein partners associated with these surface RNAs provide clues to their potential biological roles. Notably, most RNA-binding proteins associated with the identified surface RNAs have been reported as autoantigens in autoimmune diseases [16]. This association suggests potential involvement in immune recognition and pathological processes, meriting further investigation into their contributions to autoimmunity. The surface RNA landscape appears to be cell-type-specific, suggesting specialized functions across different cellular contexts.

Table: Experimentally Confirmed Surface RNA Species

RNA Category	Specific Examples	Localization Confirmation Method	Cell Types Demonstrated
LncRNAs	XIST	Intact-Surface-FISH, super-resolution microscopy	hUCB-MNCs [16]
Y-RNAs	RNY5	Intact-Surface-FISH, 3D nanoscale imaging	hUCB-MNCs [16]
Mitochondrial RNAs	MTRNR2 (rRNA), MT-TA (tRNA)	Intact-Surface-FISH, flow cytometry	HeLa cells, hUCB-MNCs [16]
Spliceosomal RNAs	U5 snRNA	Intact-Surface-FISH	HeLa cells, hUCB-MNCs [16]
Vault RNAs	VTRNA1-1	Intact-Surface-FISH	HeLa cells, hUCB-MNCs [16]

Experimental Toolkit for Surface RNA Research

Studying surface RNAs presents unique technical challenges, primarily preserving membrane integrity while achieving specific detection. Recent methodological advances now provide a rigorous framework for this emerging field.

Profiling Technologies: AMOUR

The AMOUR (A Method for Outer-membrane Unbiased RNA) technology enables accurate, membrane-preserving profiling of surface RNAs. This T7-based linear amplification method allows comprehensive identification of the outer-membrane RNA repertoire without compromising plasma membrane integrity [16]. As a proof of principle, AMOUR profiling of nucleolar and mitochondrial RNAs closely matched established databases, validating its accuracy [16].

Visualization Technologies: Intact-Surface-FISH

Intact-Surface-FISH (Fluorescence In Situ Hybridization) labels target surface RNAs on live primary cells using fluorescent DNA probes while maintaining cell viability [16]. When coupled with super-resolution microscopy and flow cytometry, this method enables robust visualization and quantification of representative surface RNAs on live cells, providing orthogonal validation of profiling data [16].

Advanced Imaging Tools: PHOTON

For intracellular RNA localization, tools like PHOTON (Photoselection of Transcriptome over Nanoscale) can identify RNA molecules at their native locations within cells [17]. PHOTON uses light-activated DNA-based molecular cages that open when exposed to a narrow laser beam (200-300 nanometers), allowing specific labeling of RNAs in illuminated regions such as particular organelles [17]. This approach has been used to demonstrate that RNAs in stress granules carry significantly more m6A modifications than those outside them, suggesting this modification plays a role in RNA translocation to these structures [17].

Surface RNA Analysis Workflow

Research Reagent Solutions

The following table outlines essential reagents and tools for investigating surface and localized RNAs, based on current methodologies.

Table: Essential Research Reagents for Surface RNA Studies

Reagent/Tool	Category	Function/Application
AMOUR Technology	Profiling Method	T7-based linear amplification for membrane-preserving surface RNA profiling [16]
Intact-Surface-FISH Probes	Detection Reagent	Fluorescent DNA probes for labeling target surface RNAs on live cells [16]
PHOTON Molecular Cages	Spatial Mapping	DNA-based cages for light-activated RNA labeling in subcellular compartments [17]
Staufen1 Antibodies	Validation Tool	Confirm association with RNA granules in neuronal processes [14]
Antisense Oligonucleotides (ASOs)	Functional Tool	Deplete specific RNAs like Malat1 to study functional consequences [14]
Cyfluthrin	Cyfluthrin High-Purity Reference Standard	High-purity Cyfluthrin for laboratory research use. Study this synthetic pyrethroid's mode of action. For Research Use Only. Not for human consumption.
Methdilazine	Methdilazine, CAS:1982-37-2, MF:C18H20N2S, MW:296.4 g/mol	Chemical Reagent

Biological Significance and Therapeutic Implications

The discovery of diverse RNA species on cell surfaces opens new dimensions for understanding cell-cell communication, immune recognition, and disease mechanisms.

Functional Roles of Surface RNAs

Surface RNAs likely serve as ligands for receptor-mediated signaling, facilitate cell adhesion, or participate in extracellular structural functions. Their association with autoantigens suggests roles in immune recognition, potentially acting as targets or regulators in autoimmune conditions [16]. In specialized cells like neurons, surface RNAs may contribute to synaptic recognition, axon guidance, and neural circuit formation.

Therapeutic Opportunities

Surface RNAs represent promising targets for diagnostic and therapeutic development. Their extracellular accessibility circumvents the challenge of intracellular delivery that has hampered many RNA-based therapeutics. Potential applications include:

• Biomarkers: Surface RNA signatures may serve as disease-specific biomarkers for cancer, neurodegenerative disorders, and autoimmune diseases.
• Vaccine Development: Immunogenic surface RNAs could be harnessed for cancer vaccine development.
• Targeted Therapies: Surface RNAs could be targeted with antibody-RNA conjugates or used as homing devices for cell-specific drug delivery.

The emerging understanding of diverse RNA species on cell surfaces, exemplified by the regulated localization of lncRNAs like Malat1, fundamentally expands the functional landscape of RNA biology. These discoveries challenge traditional compartmentalization views and reveal novel mechanisms of cellular communication and regulation. The developing toolkit for surface RNA research—including AMOUR, Intact-Surface-FISH, and PHOTON—provides powerful approaches to decipher the composition, regulation, and functions of surface RNAs across cell types and physiological states. As this field advances, surface RNAs offer promising avenues for therapeutic intervention in cancer, neurological disorders, and autoimmune diseases, potentially leveraging their extracellular accessibility for targeted approaches. Future research will likely uncover additional RNA species on cell surfaces, their trafficking mechanisms, and their specific roles in health and disease.

The conventional understanding of RNA as a solely intracellular molecule has been fundamentally challenged by the recent discovery of a diverse repertoire of RNAs residing on the cell surface. This paradigm shift reveals an unexplored dimension of cellular biology where RNA molecules, particularly glycosylated RNAs (glycoRNAs), localize to the outer cellular membrane and participate directly in critical immune processes [18] [19]. These cell surface RNAs are now recognized as active contributors to immune cell adhesion, signal transduction, and cellular recognition, thereby expanding their functional roles beyond protein coding and gene regulation.

This emerging field sits at the intersection of RNA biology and immunology, revealing how nucleic acids function in extracellular contexts. The presence of specific RNA molecules on the cell surface, often stabilized by interactions with RNA-binding proteins (RBPs) and modified by complex N-glycans, establishes a novel mechanism for cell-to-cell communication and immune surveillance [18] [20]. This whitepaper synthesizes current research to provide an in-depth technical guide on the functional implications of cell surface RNAs, with particular emphasis on their mechanisms and roles in the immune system. We will explore the quantitative characterization of these molecules, detail experimental approaches for their study, and discuss their profound implications for therapeutic development.

Cell Surface RNA Profiles and Quantitative Characterization

Initial profiling of cell surface-associated RNA has revealed a complex population of molecules distinct from intracellular transcriptomes. These RNAs are not randomly distributed but represent a specific subset of cellular RNA that becomes associated with the extracellular matrix or outer leaflet of the plasma membrane.

Composition and Physical Properties of Surface RNA

Using synthetic DNA G4 probes to capture cell surface-associated nucleic acids, researchers have quantified basic characteristics of this RNA population across different cell lines [20]. The table below summarizes key physical properties and compositional data:

Table 1: Quantitative Profile of Cell Surface Bound RNA

Characteristic	Measurement	Experimental Notes
Length Distribution	20-100 nucleotides	Predominantly short fragments
RNA Types Present	microRNAs, other cellular RNA fragments	Includes specific microRNA populations
Quantity Variation	Varies significantly between cell lines	Cell-type specific expression patterns
Response to Protease	Increases over time post-treatment	Suggests protein-mediated anchoring
Response to RNase A	Increases over time post-treatment	Reveals dynamic turnover
Functional Impact of Removal	Inhibits cell growth, promotes migration	RNase A treatment in culture medium

The data indicate that surface RNA consists primarily of internal cellular RNA fragments, with a notable presence of microRNAs, which are well-known regulatory molecules in intracellular contexts [20]. The variation in surface RNA quantity across different cell lines suggests cell-type specific regulation of RNA surface presentation, potentially correlated with distinct immunological functions.

Methodological Framework for Surface RNA Analysis

The investigation of cell surface RNAs requires specialized methodologies that distinguish them from the abundant intracellular RNA population. The following experimental workflow provides a reliable approach for profiling and validating surface-bound RNA:

Table 2: Experimental Protocol for Cell Surface RNA Profiling

Step	Method	Purpose	Key Considerations
1. Selective Labeling	DNA G4 probes or cell-impermeant labels	Tags surface-exposed RNA	Must use non-penetrating reagents
2. Controlled Digestion	Limited extracellular RNase A treatment	Validates surface exposure	Concentration and timing critical
3. RNA Isolation	Modified TRIzol protocols with click chemistry	Recovers biotinylated RNA	For Halo-seq: uses CuACC "click" chemistry [21]
4. Enrichment & Analysis	Streptavidin pulldown + RNA-seq	Identifies surface RNA repertoire	Compare to total cellular transcriptome

A critical consideration in these experiments is the use of controlled enzymatic treatments to validate surface localization. Treatment with proteases or RNase A can actually increase detectable surface RNA over time, suggesting a dynamic equilibrium between RNA association and dissociation from the cell surface [20]. This may indicate the existence of active regulatory mechanisms controlling RNA presence on the cell surface.

Mechanisms of RNA Localization to the Cell Surface

The presence of RNA on the cell surface defies traditional models of RNA containment within the cell. Understanding the mechanisms that facilitate RNA externalization and stabilization on the plasma membrane is fundamental to appreciating their functional roles.

Trafficking and Anchoring Mechanisms

RNA molecules achieve specific subcellular localization through coordinated processes involving active transport, passive diffusion, and selective anchoring. While traditionally studied in intracellular contexts, these mechanisms appear to operate for surface-localized RNAs as well:

• Active Transport: RNA is frequently transported as a component of ribonucleoprotein (RNP) granules along cytoskeletal elements. This process is mediated by motor proteins such as kinesins (on microtubules) and myosins (on actin filaments) [22]. The kinesin-1 motor protein has been specifically implicated in transporting RNAs containing pyrimidine-rich motifs in their 5' UTRs [21].

• Anchoring and Stabilization: Once transported near the cell surface, RNAs can be anchored through interactions with RNA-binding proteins (RBPs) that associate with membrane components. Proteins such as nucleolin have been identified as capable of binding RNA on the cell surface [20]. The cytoskeleton plays a dual role in both transport and anchoring, with actin filaments particularly important for refining and stabilizing RNA at specific locations [22].

• Glycosylation and Membrane Association: A seminal discovery in this field is the identification of glycoRNAs - small non-coding RNAs covalently modified by complex N-glycans [18]. This glycosylation may facilitate association with membrane components or existing glycoproteins, effectively anchoring RNAs to the cell surface.

The diagram below illustrates the primary mechanisms for RNA localization to the cell surface:

Conservation Across Cell Types

Remarkably, the mechanisms regulating RNA localization demonstrate significant conservation across different cell types with vastly different morphologies. Research has shown that RNA regulatory elements and RNA-binding proteins that regulate localization in one cell type can perform similar functions in other cell types [21]. For instance, pyrimidine-rich motifs in the 5' UTRs of ribosomal protein mRNAs are sufficient to drive RNA localization to both the basal pole of epithelial cells and the neurites of neuronal cells [21]. This cross-cell type functionality suggests the existence of a fundamental "RNA localization code" that transcends specific cellular morphologies.

Functional Roles in Immune Recognition and Adhesion

Surface-localized RNAs, particularly glycoRNAs, have emerged as significant contributors to immune system function. Their position on the cell surface enables direct participation in immune recognition and cell-cell adhesion processes.

Roles in Immune Homeostasis and Surveillance

Cell surface glycoRNAs contribute significantly to immune homeostasis and the orchestration of immune cell behavior [18]. Preliminary research indicates several specific functions:

• Immune Cell Adhesion: Surface RNAs facilitate immune cell adhesion and infiltration, potentially through direct or indirect interactions with adhesion molecules on opposing cells [18].

• Pathogen Recognition: Some surface RNAs function in pathogen recognition, serving as pattern recognition receptors or co-receptors that enhance immune detection efficiency [23].

• Immune Activation: The presence of specific surface RNA profiles can influence immune activation states, potentially through modulation of receptor signaling thresholds [18].

The diagram below illustrates how surface RNAs participate in immune recognition and adhesion:

Immunoglobulin Superfamily Parallels

The functional role of cell surface RNAs shows intriguing parallels with the Immunoglobulin Superfamily (IgSF) of proteins, which are well-established players in immune recognition and adhesion. IgSF proteins contain immunoglobulin-like domains and mediate diverse biological processes including immune recognition, cell adhesion, activation, and signal transduction [24] [23]. Like IgSF proteins, surface RNAs appear to participate in:

• Pathogen Recognition: Similar to IgSF members in invertebrates that recognize pathogens and initiate clearance responses [23].
• Cell-Cell Interaction Mediation: Facilitating specific interactions between immune cells and their targets.
• Signal Modulation: Influencing intracellular signaling pathways following ligand-receptor interactions.

These functional parallels suggest that surface RNAs may represent a nucleic acid-based system for immune recognition that complements or modifies the protein-based IgSF system.

Signaling Transduction Pathways and Mechanisms

Surface RNAs influence intracellular signaling cascades through their interactions with cell surface receptors, particularly those involved in immune signaling. This modulation affects key pathways that determine immune cell fate and function.

Key Signaling Pathways Modulated by Surface RNAs

Research indicates that surface RNAs can influence multiple signaling pathways critical for immune function. The table below summarizes the primary signaling pathways affected and their immunological significance:

Table 3: Immune Signaling Pathways Influenced by Surface RNA Interactions

Signaling Pathway	Immune Function	Impact of Surface RNA
NF-κB	Inflammatory responses, cell survival	Potential regulation of immune activation thresholds
JAK-STAT1/2	Antiviral defense, interferon response	May modulate interferon sensitivity
JAK-STAT3	Anti-inflammatory responses, cell differentiation	Possible influence on differentiation fate
TGF-β	Immunosuppression, Treg differentiation	Elevated in autoimmune contexts (e.g., RA) [25]
PI3K	T cell differentiation, metabolic regulation	May affect metabolic reprogramming
MAPK	Cell proliferation, differentiation	Potential influence on immune cell expansion

Quantitative characterization of these pathway activities using technologies like STAP-STP (Simultaneous Transcriptome-based Activity Profiling of Signal Transduction Pathways) has revealed that different immune cell types display characteristic signaling pathway activity profiles that reflect both their cell type and activation state [25]. Surface RNAs likely contribute to defining these activity profiles.

Intracellular Signal Transduction Mechanisms

The presence of RNAs on the cell surface influences intracellular signaling through several interconnected mechanisms:

• Receptor Interaction: Surface RNAs may interact directly or indirectly with cell surface receptors, modulating their activation state and subsequent signaling cascades [18] [19].

• Signal Amplification: Like traditional signal transduction pathways, surface RNA-mediated signaling likely involves amplification mechanisms where a limited number of surface interactions generate substantial intracellular responses [26] [27].

• Crosstalk with Traditional Pathways: Surface RNA signaling likely intersects with established signaling paradigms, including second messenger systems (cAMP, Ca2+, IP3), protein phosphorylation cascades, and transcriptional regulation [26].

The diagram below illustrates how surface RNA interactions influence intracellular signaling pathways:

Research Reagent Solutions and Methodological Toolkit

The investigation of cell surface RNAs requires specialized reagents and methodologies. The following toolkit summarizes essential materials for studying surface RNA biology:

Table 4: Research Reagent Solutions for Surface RNA Studies

Reagent/Method	Function	Application Examples
DNA G4 Probes	Synthetic DNA probes for surface RNA capture	Identification and quantification of surface-bound RNA [20]
Halo-seq	RNA proximity labeling technique	Mapping subcellular RNA localization [21]
Click Chemistry (CuACC)	Covalent tagging of alkyne-modified RNAs	Purification of spatially restricted RNAs [21]
Cell-Impermeant RNases	Selective degradation of surface RNAs	Validation of surface localization [20]
Single-Molecule RNA FISH	High-resolution RNA visualization	Subcellular localization confirmation [21]
csRBP Antibodies	Detect cell surface RNA-binding proteins	Identification of RNA anchoring mechanisms [19]
Metabolic Labeling	Track RNA trafficking pathways	Elucidate externalization mechanisms [18]
(R)-2-hydroxy-3-methylbutanenitrile	(R)-2-Hydroxy-3-methylbutanenitrile|CAS 10021-64-4	High-quality (R)-2-hydroxy-3-methylbutanenitrile, a valuable chiral synthon for asymmetric synthesis. For Research Use Only. Not for human or veterinary use.
Angustifoline	Angustifoline, CAS:550-43-6, MF:C14H22N2O, MW:234.34 g/mol	Chemical Reagent

These reagents enable researchers to overcome the significant technical challenge of distinguishing surface-localized RNA from the abundant intracellular RNA pool. Methods like Halo-seq are particularly valuable as they allow transcriptome-wide assessment of RNA spatial distributions across cellular compartments [21].

Implications for Disease and Therapeutic Development

The emerging understanding of surface RNA biology has profound implications for human disease mechanisms and therapeutic development, particularly in immunology and oncology.

Pathological Implications

Dysregulation of surface RNA expression or function contributes to disease pathogenesis through several mechanisms:

• Autoimmunity: Aberrant presentation of surface RNAs or csRBPs may drive autoimmune responses by creating novel antigenic epitopes or altering self-recognition patterns [19]. In rheumatoid arthritis, for example, increased TGFβ signaling pathway activity has been observed in immune cells [25].

• Cancer Immunobiology: Tumor cells may manipulate surface RNA profiles to evade immune surveillance. Changes in surface RNA composition could influence immune cell adhesion, infiltration, and activation in the tumor microenvironment [18].

• Infectious Disease: Pathogens may exploit or modify host surface RNA profiles to facilitate infection and evade immune detection.

Therapeutic Opportunities

Surface RNAs represent a novel class of therapeutic targets and diagnostic markers with significant clinical potential:

• Diagnostic Biomarkers: The specific profile of surface RNAs on immune cells or tumor cells may serve as biomarkers for disease classification, progression monitoring, or treatment response prediction.

• Immunomodulatory Therapies: Targeted manipulation of surface RNA interactions could enable precise tuning of immune responses for autoimmune diseases, cancer immunotherapy, or vaccine adjuvants.

• Drug Development: Understanding how surface RNAs influence signaling pathway activity (NF-κB, JAK-STAT, etc.) provides new avenues for therapeutic intervention in immune-related disorders [25].

The discovery of functionally active RNAs on the cell surface represents a fundamental expansion of RNA biology into the extracellular space. These surface RNAs, particularly glycoRNAs, play critical roles in immune cell adhesion, signal transduction, and cellular recognition—functions traditionally ascribed to membrane proteins. Their influence on key signaling pathways, including NF-κB, JAK-STAT, and TGF-β, positions them as significant regulators of immune homeostasis.

As research methodologies advance, particularly in spatial transcriptomics and single-cell analysis, our understanding of surface RNA biology will continue to deepen. This emerging field not only enhances our fundamental knowledge of cell biology but also opens new avenues for therapeutic intervention in immunology, oncology, and infectious disease. The continued elucidation of surface RNA mechanisms and functions will undoubtedly yield novel insights into cell-cell communication and immune regulation in the coming years.

A Technical Toolkit: Profiling and Targeting Cell Surface RNA with Advanced Omics and Imaging

Surface-seq represents a groundbreaking methodological framework for the selective sequencing of nuclear-encoded RNAs that are stably associated with the extracellular surface of cell membranes. This technical guide details the experimental workflows, validation methodologies, and functional implications of Surface-seq technology, which enables the systematic identification of membrane-associated extracellular RNAs (maxRNAs). Contrary to conventional understanding that nuclear-encoded RNAs predominantly reside intracellularly, Surface-seq demonstrates that specific RNA fragments are naturally displayed on the outer cell surface and contribute to cellular interactions. This whitepaper provides researchers with comprehensive protocols for implementing Surface-seq, validating maxRNA localization, and assessing functional significance, thereby expanding our understanding of RNA's role in cell-surface biology and creating new avenues for therapeutic development.

The cell surface serves as the crucial interface between a cell's interior and its external environment, traditionally characterized by its complement of proteins, glycans, and lipids that facilitate signal sensing, extracellular matrix anchoring, and intercellular communication. The contribution of RNA to cell surface functions has remained largely unexplored until recently due to the predominant assumption that nuclear-encoded RNAs are confined within intact cellular membranes [1]. Emerging evidence now challenges this paradigm, suggesting that specific RNAs stably associate with the extracellular layer of the plasma membrane under physiological conditions.

Surface-seq technology was developed to systematically investigate these membrane-associated extracellular RNAs (maxRNAs), defined as nuclear-encoded RNAs stably attached to the cell surface and exposed to the extracellular space [28] [1]. This differs fundamentally from vesicle-encapsulated or cell-free RNAs that are not directly membrane-anchored. The discovery of maxRNAs suggests an expanded role for RNA in cell-cell and cell-environment interactions, potentially opening new avenues for biomarker discovery and therapeutic intervention [7]. Compared to protein targets, maxRNAs offer distinct advantages for therapeutic development because they can be targeted by specific antisense oligonucleotides, which are generally easier to develop and optimize than antibody-based therapeutics [7].

Surface-seq Core Methodology

Technology Foundation and Principles

Surface-seq leverages a nanotechnology approach originally developed for creating membrane-coated nanoparticles [1] [7]. The core innovation lies in extracting the plasma membrane from cells and assembling it around polymeric cores to form membrane-coated nanoparticles (MCNPs) that maintain the natural inside-outside orientation of the membrane, with surface molecules facing outward [1]. This process rigorously removes intracellular contents while preserving RNAs that are stably associated with the extracellular layer of the cell membrane [7]. The MCNP platform thereby enables selective access to maxRNAs that would otherwise be contaminated by abundant intracellular RNAs in whole-cell analyses.

Experimental Workflows and Variations

The Surface-seq methodology comprises two primary technical variations that enable differential RNA analysis:

• Variation A - Total Membrane-Associated RNA Profiling: After MCNP assembly and washing, total RNA is extracted using phenol-chloroform and constructed into a sequencing library without distinguishing membrane orientation [1]. This approach captures all membrane-associated RNAs regardless of their spatial orientation relative to the membrane.

• Variation B - Outside-Facing RNA Enrichment: Following MCNP assembly, RNAs exposed on the outer surface are directly ligated to a 3′ RNA adaptor while still membrane-bound [1]. The RNA is subsequently purified and ligated with a 5′ adaptor. This selective ligation strategy specifically enriches for outside-facing membrane-associated RNAs in the final sequencing library.

Table 1: Surface-seq Technical Variations and Their Applications

Variation	RNA Population Targeted	Key Processing Step	Primary Application
Variation A	Total membrane-associated RNA	Phenol-chloroform extraction post-MCNP assembly	Comprehensive identification of all membrane-associated RNAs
Variation B	Outside-facing RNA only	Direct 3′ adaptor ligation to membrane-bound RNA	Selective enrichment of extracellularly exposed maxRNAs
Chelidonine hydrochloride	Chelidonine hydrochloride, CAS:4312-31-6, MF:C20H20ClNO5, MW:389.8 g/mol	Chemical Reagent	Bench Chemicals
2,3-Dihydroisoginkgetin	2,3-Dihydroisoginkgetin, CAS:828923-27-9, MF:C32H24O10, MW:568.5 g/mol	Chemical Reagent	Bench Chemicals

The workflow for both variations includes subsequent library preparation, sequencing, and bioinformatic analysis to identify candidate maxRNAs. The sequencing reads typically display non-uniform distribution across transcript regions, with enrichment at specific segments rather than the entire transcript length [1].

Validation and Functional Assessment Methods

Surface-FISH for maxRNA Visualization

Surface-FISH (RNA fluorescence in situ hybridization on the cell surface) was developed to validate the extracellular localization of Surface-seq-identified maxRNAs [1]. This technique adapts single-molecule RNA-FISH by omitting the cell membrane permeabilization step, thereby restricting probe access to extracellularly exposed RNAs [1]. The protocol employs quantum-dot-labeled oligonucleotide probes (40 nt each) targeting specific regions of candidate maxRNAs, with controlled probe sets containing centrally located mutations serving as specificity controls [1].

Key Experimental Steps:

• Probe Design: Five quantum-dot-labeled oligonucleotide probes (40 nt each) designed against target transcript regions identified by Surface-seq
• Control Probes: Mutated versions with six central base substitutions to establish background signal levels
• Hybridization: Live cells incubated with probes without membrane permeabilization
• Signal Detection: Imaging flow cytometry or microscopy to detect surface-bound probes
• Membrane Integrity Validation: Combined with transmission-through-dye (TTD) microscopic analysis to confirm intact membranes [1]

In validation studies, nearly all EL4 cells treated with Malat1 and Neat1 probes exhibited Surface-FISH signals (1-10 foci per cell), while most cells treated with control probes showed no signal (median = 0), with statistical significance of p < 0.0001 by Wilcoxon rank tests [1]. The TTD analysis confirmed that these signals occurred on cells with intact membranes, excluding the possibility of RNA leakage from damaged cells [1].

Functional Interrogation via Antisense Oligonucleotides

The functional role of maxRNAs can be assessed using antisense oligonucleotides (ASOs) applied extracellularly to hybridize with exposed transcript regions [28] [1]. This approach was used to investigate maxRNA function in human peripheral blood mononuclear cells (PBMCs), where monocytes were identified as the primary maxRNA-positive population [1].

Experimental Protocol:

• Cell Preparation: Freshly isolated human PBMCs from multiple donors (e.g., 120,000 cells per subject, split into aliquots)
• ASO Treatment: Extracellular application of ASOs targeting specific maxRNAs (e.g., FNDC3B and CTSS transcripts)
• Functional Assay: Assessment of cellular interactions such as monocyte adhesion to vascular endothelial cells
• Control Conditions: Include randomized oligonucleotide libraries, species-specific irrelevant RNAs, and fluorophore-only controls

Functional studies demonstrated that extracellular application of ASOs targeting FNDC3B and CTSS transcripts significantly inhibited monocyte adhesion to vascular endothelial cells, providing evidence for the functional relevance of these maxRNAs in cellular interaction processes [28] [1].

Table 2: Quantitative Surface-seq Validation Data from Key Studies

Experimental Measure	Value/Result	Experimental Context	Statistical Significance
Surface-FISH positive cells	Nearly 100% with target probes vs. median 0 with controls	EL4 cells probing Malat1 and Neat1	p < 0.0001 (Wilcoxon rank test)
maxRNA+ PBMCs	4.8% of total PBMCs	Human peripheral blood mononuclear cells	27-fold > control groups (p < 0.005)
Cell-type specificity	>10% of CD14+ monocytes, ~3% of CD3ε+ T cells	PBMC subpopulations	p < 0.005 (t-test)
Functional effect	Inhibition of monocyte adhesion	ASO targeting of FNDC3B and CTSS	Significant inhibition reported

Research Reagent Solutions for Surface-seq

Table 3: Essential Research Reagents for Surface-seq Experiments

Reagent/Category	Specific Examples	Function/Purpose
Membrane Coating Materials	Polymeric cores for MCNP assembly	Maintain membrane orientation and remove intracellular contents
RNA Adaptors	3′ and 5′ RNA adaptors with distinct barcodes	Selective ligation to outside-facing RNAs (Variation B)
Surface-FISH Probes	Quantum-dot-labeled 40nt oligonucleotides; mutated control probes	Visualization and validation of surface RNA localization
Antisense Oligonucleotides	ASOs targeting FNDC3B, CTSS, and other maxRNAs	Functional perturbation of maxRNA-mediated processes
Cell Markers	CD14, CD3ε, CD19 antibodies with fluorescence tags	Cell type identification and sorting in heterogeneous populations
Viability Assays	Transmission-through-dye (TTD) reagents	Confirmation of membrane integrity during Surface-FISH
Sequencing Library Prep	Reverse transcription reagents, PCR amplification kits	Library construction from membrane-associated RNA

Integration with Complementary Technologies

Surface-seq data can be integrated with complementary multi-omics approaches to provide a comprehensive understanding of cell surface biology. Several relevant technologies include:

• CITE-seq (Cellular Indexing of Transcriptomes and Epitopes by Sequencing): Simultaneously measures gene expression and cell surface protein abundance using DNA-barcoded antibodies [29] [30]. While CITE-seq focuses on surface proteins, it can complement Surface-seq by providing parallel data on the protein composition of the same cell surfaces.

• SPIDER (Surface Protein Imputation using Deep Ensembles): A computational approach that predicts surface protein abundance from single-cell transcriptomes using context-agnostic zero-shot deep ensemble models [31]. SPIDER can predict abundance for over 2,500 cell surface proteins and demonstrates how computational methods can extend experimental data.

• TARGET-seq+: A recently optimized protocol that combines RNA sequencing, cell surface protein analysis, and genotyping in single cells with improved sensitivity [32]. This method addresses the challenge of studying somatic mutations in pre-malignant and cancerous tissues while capturing surface protein expression.

The integration of Surface-seq with these technologies creates a powerful framework for comprehensive cell surface analysis, enabling researchers to correlate maxRNA presence with surface protein expression, genetic variations, and spatial context in complex biological systems.

Future Directions and Applications

The discovery of maxRNAs through Surface-seq technology opens multiple avenues for future research and therapeutic development. Key areas for further investigation include:

• Mechanistic Studies: Understanding how maxRNAs are transported to the cell surface and anchored there represents a crucial next step [7]. This includes elucidating the biogenesis pathways and molecular machinery responsible for maxRNA localization.

• Diversity Assessment: Investigating the diversity of cell types, genes, environmental cues, and biogenesis pathways associated with maxRNA expression will reveal the full scope of this phenomenon [7].

• Therapeutic Development: Since maxRNAs are accessible on the cell surface without requiring intracellular delivery, they present attractive targets for antisense oligonucleotide therapeutics [7]. The demonstrated functional impact of maxRNA targeting on monocyte adhesion suggests potential applications in modulating cellular interactions in disease contexts.

• Biomarker Discovery: The cell-type specificity of maxRNA presentation, with monocytes showing particularly high maxRNA levels, suggests potential for diagnostic and prognostic biomarker development [1].

Surface-seq technology substantially expands our ability to interpret the human genome by revealing that a portion of the genome may regulate cellular presentation and interactions through maxRNA production [7]. This expanded understanding of RNA biology at the cell surface creates new opportunities for basic research and translational applications across biomedical fields.

The subcellular localization of RNA is intimately tied to its function, serving as a key determinant of cellular homeostasis [33]. Asymmetrically distributed RNAs underlie critical biological processes including organismal development, local protein translation, and the three-dimensional organization of chromatin [33]. Where an RNA molecule is located within the cell ultimately determines whether it will be stored, processed, translated, or degraded [33]. This spatial regulation is particularly crucial for cell surface RNA localization, where localized translation enables rapid response to extracellular signals and environmental changes without requiring protein trafficking from distant cellular regions.

Despite its fundamental importance, comprehensively characterizing the spatial transcriptome has presented significant challenges. While classical approaches like biochemical fractionation followed by RNA sequencing ("fractionation-seq") have been applied transcriptome-wide, they cannot be applied to organelles that are impossible to purify, such as the nuclear lamina and outer mitochondrial membrane [33]. Even for purifiable organelles, contamination issues persist [33]. Direct visualization by microscopy, while powerful, faces limitations including the need for designed probe sets, potential relocalization during fixation, spatial resolution limits, and limited information content compared to sequencing [33].

To address these challenges, proximity labeling techniques have emerged as transformative tools that enable mapping of thousands of endogenous RNAs simultaneously in living cells [33] [34]. These approaches allow researchers to capture full sequence details of any RNA type, enabling comparisons across variants and isoforms with high spatial specificity [33]. This technical guide provides an in-depth examination of two leading proximity labeling methods—APEX-seq and Halo-seq—framed within the context of advancing research into cell surface RNA localization and its therapeutic applications.

Technical Fundamentals of Proximity Labeling

Proximity labeling techniques share a common principle: using genetically engineered enzymes targeted to specific subcellular locations to label nearby biomolecules [34] [35]. The core innovation involves spatially restricted catalytic reactions that tag endogenous molecules within a limited radius of the enzyme's active site, followed by affinity purification and sequencing of the labeled species [33] [34] [35].

These techniques address a critical methodological gap in spatial biology. Traditional biochemical fractionation cannot access many cellular compartments, while microscopy-based approaches struggle with throughput and resolution [33]. Proximity labeling uniquely enables comprehensive, nanometer-resolution mapping of RNA localization in living cells across virtually any subcellular niche [33] [34].

The labeling radius differs significantly between enzymes. APEX2 generates phenoxyl radicals with an extremely short half-life (<1 ms), theoretically restricting labeling to a 20 nm radius [35]. In contrast, HRP has a broader labeling range of 200-300 nm [35], while the reactive oxygen species generated in Halo-seq diffuse approximately 100 nm from their source [34]. This differential labeling radius represents a key consideration when selecting the appropriate technique for specific biological questions.

Table 1: Comparison of Proximity Labeling Enzyme Properties

Enzyme	Labeling Radius	Activation Method	Reactive Species Half-life	Primary Applications
APEX2	~20 nm	Hâ‚‚Oâ‚‚ addition	<1 ms [35]	RNA, protein, DNA profiling [33] [35]
HRP	200-300 nm	Hâ‚‚Oâ‚‚ addition	Not specified	Historically used for proximity labeling
HaloTag (with DBF ligand)	~100 nm	Green light exposure	Not specified	RNA and protein profiling [34]

APEX-seq: Methodological Framework

Core Principles and Mechanism

APEX-seq utilizes the engineered peroxidase APEX2 to directly biotinylate RNA molecules in close proximity to the enzyme [33]. The method builds on previous work using APEX2 for spatial proteomics, leveraging its ability to catalyze the one-electron oxidation of biotin-phenol (BP) in the presence of hydrogen peroxide (Hâ‚‚Oâ‚‚) [33]. The resulting biotin-phenoxyl radical is short-lived and covalently conjugates to electron-rich regions of RNA molecules, primarily targeting guanine-rich sequences [33].

The APEX2 enzyme can be targeted to specific subcellular locales through genetic fusion to proteins or peptides with known localization [33]. In practice, researchers generate cell lines stably expressing APEX2 fused to localization signals—for example, targeting the outer mitochondrial membrane, endoplasmic reticulum membrane, nuclear lamina, or nucleolus [33]. Correct targeting must be verified by immunofluorescence staining against organelle markers before proceeding with labeling experiments [33].

Experimental Workflow and Protocol

The APEX-seq protocol involves several critical steps that must be optimized for high spatial specificity and minimal background:

• Cell Line Development: Generate stable cell lines expressing APEX2 fused to a protein that localizes to the subcellular compartment of interest. Verify correct localization via immunofluorescence [33].

• Biotin Labeling: Incubate cells with membrane-permeable biotin-phenol (BP) for optimal loading (typically 30 minutes), followed by addition of Hâ‚‚Oâ‚‚ to initiate the labeling reaction for a precisely timed 1-minute window [33]. The short reaction time is critical as the biotin-phenoxyl radical has a half-life of <1 ms, ensuring nanometer spatial resolution [35].

• Reaction Termination and RNA Extraction: Immediately after the 1-minute labeling, quench the reaction by removing Hâ‚‚Oâ‚‚ and adding radical scavengers. Extract total RNA using standard methods such as TRIzol, maintaining RNA integrity [33].

• Streptavidin Enrichment: Incubate the extracted RNA with streptavidin-coated beads under denaturing conditions to dissociate non-covalent complexes. Include optimized denaturing washes to ensure only biotinylated RNA species are enriched [33].

• Library Preparation and Sequencing: Proceed with standard RNA-seq library preparation from the enriched RNA fraction, followed by high-throughput sequencing [33].

Table 2: Key Reagents for APEX-seq

Reagent	Function	Considerations
APEX2 Fusion Construct	Targets labeling to specific subcellular locations	Must verify localization via immunofluorescence [33]
Biotin-phenol (BP)	Substrate for peroxidase reaction	Membrane-permeable; requires optimization of concentration [33]
Hydrogen Peroxide (Hâ‚‚Oâ‚‚)	Activates peroxidase activity	Critical to optimize concentration and labeling time (typically 1 min) [33]
Streptavidin Beads	Affinity purification of biotinylated RNA	Require denaturing wash conditions to remove non-specifically bound RNA [33]

Applications and Validation

APEX-seq has been successfully applied to map transcriptomes at nine distinct subcellular locations, generating a nanometer-resolution spatial map of the human transcriptome [33] [36]. Key biological insights from these applications include:

• Radial organization of the nuclear transcriptome, with gating at the inner surface of the nuclear pore for cytoplasmic export of processed transcripts [33]
• Identification of two distinct pathways for mRNA localization to mitochondria, each associated with specific transcript sets for building complementary macromolecular machines within the organelle [33]
• Direct detection of functional mRNA delivery to the endoplasmic reticulum, the major site of translation for secretory proteins, highlighting the method's utility for studying therapeutic mRNA delivery [37]

Validation experiments demonstrate APEX-seq's remarkable specificity. When targeted to the endoplasmic reticulum membrane (ERM), APEX-seq showed high enrichment of secretory mRNAs (ERM-proximal "true positives") but not negative-control cytosolic mRNAs encoding non-secretory proteins [33]. This nanometer-scale resolution enables distinction between ER-proximal RNAs and cytosolic RNAs only nanometers from the ERM [33].

Halo-seq: A Complementary Approach

Principle and Mechanism

Halo-seq represents an alternative proximity labeling strategy that utilizes the HaloTag protein and a specialized ligand, dibromofluorescein (DBF), to label proximal RNAs [34]. The HaloTag is a modified haloalkane dehalogenase that forms a specific covalent bond with synthetic ligands [34]. In Halo-seq, the HaloTag is fused to a protein with known subcellular localization, effectively positioning the labeling system at the cellular site of interest [34].

The unique feature of Halo-seq is its photoactivatable labeling mechanism. When exposed to green light, the DBF ligand produces highly reactive oxygen species that oxidize nearby biomolecules, including RNA and proteins, making them susceptible to nucleophilic attack by an added alkyne-containing amine, propargylamine [34]. This enables temporal control of the labeling reaction through light exposure, a significant advantage for capturing dynamic localization processes.

Experimental Workflow

The Halo-seq protocol involves distinct steps that differentiate it from APEX-seq:

• Cell Line Development and Validation: Generate cell lines expressing doxycycline-inducible HaloTag fusion proteins. Verify correct localization using fluorescent Halo ligands and fluorescence microscopy (Basic Protocol 1) [34].

• In Vivo RNA Alkynylation: Incubate cells with DBF ligand for optimal labeling, then expose to green light to activate the labeling reaction in the presence of propargylamine. This results in specific alkynylation of RNA molecules near the HaloTag fusion protein [34].

• RNA Extraction and Biotinylation: Extract total RNA, then perform an in vitro copper-catalyzed "Click" reaction to conjugate biotin-azide to the alkynylated RNA [34].

• Quality Control and Enrichment: Verify biotinylation efficiency via RNA dot blot, then enrich biotinylated RNA using streptavidin beads [34].

• Sequencing and Analysis: Proceed with RNA-seq library preparation and high-throughput sequencing, followed by computational identification of localized transcripts [34].

Advantages and Applications

Halo-seq offers several distinct advantages for spatially resolved transcriptomics:

• Temporal control through light activation enables precise interrogation of dynamic RNA localization processes [34]
• Compatibility with various cell types, including those unsuitable for APEX-seq due to biotin starvation toxicity [34]
• Not biased toward any transcript type and preserves isoform information [34]
• Flexible profiling of diverse subcellular RNA populations without requiring specialized instrumentation [34]

The method has been successfully applied to identify localized RNAs in various cellular contexts, facilitating discovery of RNA localization regulatory mechanisms [34]. Its temporal control makes it particularly valuable for studying processes such as stress response, where RNA localization changes rapidly in response to environmental stimuli.

Comparative Analysis and Technical Considerations

Method Selection Guide

Choosing between APEX-seq and Halo-seq requires careful consideration of experimental goals and biological context:

Table 3: Comparative Analysis of APEX-seq and Halo-seq

Parameter	APEX-seq	Halo-seq
Labeling enzyme	APEX2 (engineered peroxidase)	HaloTag (engineered dehalogenase)
Activation mechanism	Hâ‚‚Oâ‚‚ addition	Green light exposure
Temporal control	Limited (seconds-minutes)	High (seconds) [34]
Labeling radius	~20 nm [35]	~100 nm [34]
Spatial resolution	Higher (nanometer scale) [33]	Lower (~100 nm) [34]
Compatibility	Toxic in biotin-sensitive cells [33]	Broad cell type compatibility [34]
Endogenous RNA bias	No bias toward specific RNA classes [33]	No bias toward specific RNA classes [34]
Key applications	Organelle transcriptomics, nuclear organization [33]	Dynamic processes, stress responses [34]

Technical Considerations and Optimization

Successful implementation of proximity labeling techniques requires attention to several critical parameters:

• Enzyme Targeting and Expression: Both methods require verification of correct subcellular localization of the fusion protein via immunofluorescence or comparison with known markers [33] [34]. Inducible expression systems are recommended for Halo-seq to minimize cell-to-cell variation [34].

• Labeling Conditions Optimization: For APEX-seq, the concentration of BP and Hâ‚‚Oâ‚‚ and the 1-minute reaction time must be optimized to maximize signal-to-noise ratio [33]. For Halo-seq, DBF concentration, light exposure duration, and propargylamine concentration require empirical determination [34].

• Controls and Normalization: Critical controls include omission of BP or Hâ‚‚Oâ‚‚ (APEX-seq) or light activation (Halo-seq). Incorporation of biotinylated spike-in RNA enables normalization and optimization of pull-down conditions [37].

• RNA Integrity and Library Preparation: Maintain RNA integrity throughout extraction and processing steps. Use standardized RNA-seq library preparation methods compatible with potentially fragmented RNA from the labeling process.

Applications in Cell Surface RNA Localization Research

Biological Insights and Therapeutic Implications

Proximity labeling techniques have revealed profound insights into RNA localization biology with particular relevance to cell surface processes:

• Spatial Organization of Translation: APEX-seq has demonstrated that endoplasmic reticulum-localized transcripts are more efficiently recruited to cytosolic granules during stress responses than cytosolic RNAs, revealing specialized regulatory mechanisms for membrane-targeted mRNAs [38].

• Mitochondrial RNA Import: APEX-seq identified two distinct pathways for mRNA localization to mitochondria, each associated with specific transcript sets for building complementary macromolecular machines within the organelle [33]. This organization enables coordinated assembly of mitochondrial complexes.

• Therapeutic mRNA Delivery: Adapted APEX-seq approaches have quantitatively measured functional mRNA delivery to the endoplasmic reticulum, demonstrating that delivery to this compartment correlates with efficient translation—a critical consideration for optimizing mRNA therapeutics [37].

Integration with Multi-Omics Approaches

The true power of proximity labeling emerges when integrated with complementary spatial omics technologies:

• Combined RNA and Protein Mapping: Recent advances enable simultaneous interrogation of RNA and protein subcellular localization through methods like LoRNA and dLOPIT [38]. This integrated framework provides a systems-level view of spatial organization.

• Dynamic Relocalization Studies: During the unfolded protein response, simultaneous quantification of transcriptome and proteome reorganization revealed that ER-localized RNAs undergo extensive relocalization to cytosolic granules, while noncoding RNAs with similar properties do not, indicating the importance of trans factors in determining RNA localization [38].

Emerging Innovations and Future Perspectives

The field of spatially resolved transcriptomics continues to evolve rapidly, with several promising directions emerging:

Novel Proximity Labeling Systems: Recent patent literature describes innovative proximity labeling complexes that fuse protein A with ascorbate peroxidase, enabling recognition of target proteins through specific antibodies without requiring genetic fusion [35]. This approach expands applicability to post-translationally modified proteins and complex systems resistant to genetic manipulation.

Multi-modal Integration: Future applications will increasingly combine proximity labeling with other spatial technologies, including advanced imaging and single-cell sequencing, to build comprehensive spatial models of cellular organization.

Therapeutic Development: As evidenced by applications studying mRNA delivery to the endoplasmic reticulum [37], proximity labeling techniques will play an increasingly important role in optimizing nucleic acid therapeutics by revealing determinants of productive delivery and localized translation.

In conclusion, APEX-seq and Halo-seq represent powerful complementary approaches for spatially resolved transcriptomics, each with distinct advantages and applications. When properly implemented and integrated with orthogonal validation methods, these proximity labeling techniques provide unprecedented insights into the spatial organization of the transcriptome, with particular utility for advancing research into cell surface RNA localization and its therapeutic applications.

Single-Molecule Fluorescence In Situ Hybridization (smFISH) has revolutionized our ability to visualize and quantify RNA molecules at subcellular resolution. Conventional smFISH requires cell permeabilization to allow access of fluorescently labeled probes to intracellular transcripts, a process that alters native cellular architecture and precludes the study of membrane-associated RNAs in their intact physiological context. This whitepaper introduces Surface-FISH, a specialized adaptation that forgoes permeabilization to specifically detect RNAs at or near the cell surface. We provide a comprehensive technical guide detailing the theoretical foundation, optimized protocols, and analytical framework for Surface-FISH, positioning it as an essential methodology for elucidating the roles of localized transcripts in processes such as localized translation, cell signaling, and adhesion within native membrane environments.

The spatial distribution of mRNA is a fundamental regulatory mechanism in gene expression. RNA localization enables cellular polarization, local protein synthesis, and rapid response to extracellular cues [39]. While traditional smFISH has mapped intracellular RNA territories, a growing body of evidence suggests that various RNAs, including those encoding membrane proteins, secreted factors, and certain non-coding RNAs, are associated with the inner leaflet of the plasma membrane or are present in extracellular contexts. The investigation of this surface-associated transcriptome is technically challenging, as standard smFISH protocols employ detergents like Triton X-100 for permeabilization, which strips away membrane integrity and disrupts surface-bound complexes [40] [41].

Surface-FISH addresses this limitation by eliminating the permeabilization step, thereby preserving the plasma membrane while enabling the detection of RNAs in immediate proximity to it. This technique is particularly valuable for:

• Studying the local translation of receptors and adhesion molecules.
• Investigating RNA-based extracellular biomarkers.
• Validating the surface localization of RNAs identified via other methods.
• Screening for therapeutics that target membrane-associated RNA-protein complexes.

This guide details the core methodology, providing researchers with a framework to apply Surface-FISH within a broader thesis on the functional significance of cell surface RNA.

Surface-FISH Core Methodology

The fundamental principle of Surface-FISH involves the hybridization of multiple short, fluorescently labeled DNA oligonucleotides to target RNA sequences in fixed cells without subsequent permeabilization. The key modification from standard smFISH is the preservation of the plasma membrane, which confines detection to externally accessible RNAs.

Workflow and Conceptual Framework

The following diagram illustrates the critical procedural divergence between conventional smFISH and the Surface-FISH protocol, highlighting the omission of permeabilization.

Critical Reagents and Experimental Components

The success of Surface-FISH hinges on the quality and specificity of its core components. The table below summarizes the essential reagents and their optimized specifications.

Table 1: Essential Research Reagent Solutions for Surface-FISH

Reagent / Component	Function / Role	Key Specifications & Notes
Fluorescent Oligo Probe Set	Hybridizes to target RNA; signal generation.	~20-50 single-labeled 20-mer oligonucleotides tiling the target RNA [40] [42]; Quasar570 or similar fluorophores recommended.
Fixative	Preserves cellular architecture and RNA location.	4% Paraformaldehyde (PFA) in PBS. Avoid methanol fixation [41].
Hybridization Buffer	Creates optimal environment for probe-RNA binding.	Contains formamide, SSC, dextran sulfate, and blocking agents (e.g., tRNA, BSA) [40].
Wash Buffers	Removes unbound and nonspecifically bound probes.	Saline-sodium citrate (SSC) buffer with precise post-hybridization stringency control [40] [43].
Blocking Agent	Reduces nonspecific probe binding.	Bovine serum albumin (BSA) or fish gelatin combined with E. coli tRNA [40].
Mounting Medium	Preserves samples for microscopy.	Anti-fade reagent (e.g., ProLong); may include DAPI for nuclear counterstaining [40].

Detailed Experimental Protocol

This protocol is optimized for adherent animal cells grown on glass coverslips or in multi-well plates [40] [39].

Cell Preparation and Fixation

• Culture Cells: Grow adherent cells on sterile, #1.5 thickness, 18 mm round glass coverslips placed in a 12-well plate.
• Rinse: Aspirate culture medium and gently rinse cells twice with pre-warmed, sterile PBS (with Ca²⁺/Mg²⁺) to preserve cell adhesion [41].
• Fix: Immediately add 1 mL of freshly prepared 4% PFA in PBS to each well. Incubate for 20 minutes at room temperature.
  • Critical Note: Do not use Triton X-100 or any other permeabilizing agent at any point.
• Quench & Rinse: Remove PFA and rinse cells three times with PBS to remove all traces of fixative.

Pre-Hybridization and Blocking

• Equilibrate: Incubate cells in 1 mL of pre-hybridization (Pre-hyb) buffer for 10 minutes. This buffer typically consists of 2x SSC with 10-20% formamide [40].
• Block (Optional but Recommended): To minimize background, incubate cells in a blocking solution of PBS containing 2% fish gelatin for 30 minutes at room temperature [41].

Hybridization

• Prepare Probe Mix: Dilute the fluorescent probe set to a working concentration (e.g., 0.1-1 ng/µL per probe) in hybridization buffer. The hybridization buffer contains formamide (concentration determines stringency), SSC, dextran sulfate (to enhance hybridization efficiency), and blocking agents [40].
• Hybridize: Apply 100 µL of the probe mixture directly to the fixed cells on the coverslip. To prevent evaporation, place the coverslip cell-side-down on a Parafilm sheet in a sealed, humidified hybridization chamber.
• Incubate: Incubate the chamber in the dark at 37°C for 12-16 hours (overnight).

Post-Hybridization Washes

Stringent washing is critical for low background.

• Initial Washes: Carefully return the coverslip to the 12-well plate and wash twice with pre-warmed wash buffer A (e.g., 2x SSC with 10% formamide) for 15 minutes each at 37°C.
• Stringent Wash: Perform a final wash with wash buffer B (e.g., 1x SSC or 0.5x SSC) for 10 minutes at room temperature.
• Nuclear Stain (Optional): Incubate with DAPI (e.g., 1 µg/mL in PBS) for 5 minutes, followed by a brief PBS rinse.

Mounting and Imaging

• Mount: Briefly air-dry the edges of the coverslip and mount it onto a glass slide using 10-15 µL of anti-fade mounting medium.
• Seal: Seal the edges of the coverslip with clear nail polish or a commercial sealant to prevent drying and movement.
• Image: Acquire z-stack images using a wide-field or confocal fluorescence microscope equipped with a high-numerical aperture (NA) 63x or 100x oil immersion objective and a sensitive camera [40] [43]. Ensure all images are acquired with identical settings for quantitative comparisons.

Data Analysis and Quantification for Surface-FISH

The analytical workflow for Surface-FISH focuses on confirming the extracellular localization of signals and quantifying them relative to intracellular benchmarks.

Analytical Workflow and Validation Logic

The analysis hinges on a comparative strategy to distinguish true surface signals from potential residual intracellular background. The following logic path guides the researcher through this validation process.

Key Quantitative Metrics and Parameters

The quantitative data extracted from Surface-FISH experiments can be benchmarked against established performance metrics for smFISH. The following table provides expected value ranges and performance indicators for a successful Surface-FISH experiment.

Table 2: Quantitative Data and Performance Metrics for Surface-FISH

Parameter	Description	Typical Range / Benchmark
Detection Efficiency	Percentage of total cellular RNA detected by Surface-FISH compared to permeabilized smFISH.	Varies by target; 1-20% for a bona fide surface-localized RNA.
Signal-to-Background Ratio	Ratio of mean fluorescence intensity of a spot to the mean local background.	Should be > 3-5 for reliable single-molecule detection [40].
Spot Count per Cell	Absolute number of RNA molecules detected at the cell surface.	Target-dependent; can range from single molecules to hundreds.
Limit of Detection (LOD)	Lowest number of mRNA molecules detectable per cell.	As low as 1 molecule/cell with optimized probes [43].
Coefficient of Variation (CV)	Measure of spot intensity uniformity for the same target.	< 30% indicates a well-tiled and efficient probe set [40].
Background Fluorescence	Non-specific fluorescence in negative control channels.	Should be minimal and non-punctate; can be quantified as mean intensity per cell area.

Advanced Image Analysis

• Automated Spot Detection: Use software like FISH-quant [40] or Localize [43] to apply 3D Gaussian fitting algorithms for identifying diffraction-limited spots, which correspond to single RNA molecules.
• Classification with Fuzzy C-Means Clustering: For robust classification of positive vs. negative signals amidst variable background, employ Fuzzy C-Means (FCM) clustering on intensity data. This method, adapted from environmental microbiology [44], classifies signals without relying on a single, arbitrary intensity threshold, improving accuracy in heterogeneous samples.
• Spatial Coordinate Mapping: Determine the precise spatial coordinates (x, y, z) of each detected RNA molecule relative to the DAPI stain (nucleus) and, if available, a co-stained membrane marker. This allows for quantitative analysis of RNA distribution relative to cellular compartments.

Discussion and Future Perspectives

Surface-FISH establishes a new capability for directly probing the outermost layer of the cellular transcriptome. Its non-permeabilizing nature makes it uniquely suited for validating the surface localization of RNAs in their native membrane context, a crucial step for research focused on local translation and extracellular RNA function. A significant application lies in drug discovery, where the technique can be used in high-content screening (HCS) platforms to identify compounds that alter the surface presentation of pathogenic RNAs, such as those containing expanded repeats in neurological disorders [39].

Future developments will likely focus on multiplexing to enable the simultaneous detection of multiple RNA targets on the same cell surface, akin to multiplexed intracellular smFISH [45]. Furthermore, combining Surface-FISH with live-cell imaging techniques could provide dynamic insights into the trafficking of RNAs to and from the plasma membrane. As our understanding of the surface-associated transcriptome expands, Surface-FISH is poised to become an indispensable tool in the molecular biologist's toolkit, bridging the gap between intracellular RNA biology and extracellular signaling.

The traditional paradigm of molecular biology, which positioned RNA primarily as a messenger within the cell's interior, has been fundamentally expanded. A groundbreaking discovery has revealed that specific small noncoding RNAs, termed glycoRNAs, localize to the surface of mammalian cells, modified with sialylated and fucosylated N-glycans [46]. These glycoRNAs have been shown to interact with specific Siglec family receptors and P-selectin, suggesting a novel layer of cell-cell communication and immune recognition [46]. This finding positions the cell surface as a new frontier for RNA biology, presenting a unique therapeutic opportunity. The functional interrogation of these cell surface RNAs is thus critical for understanding their biological roles and for harnessing their potential in drug development.

Antisense oligonucleotides (ASOs) represent a powerful and versatile tool for this functional interrogation. ASOs are short, single-stranded synthetic DNA or RNA molecules, typically 15-21 nucleotides in length, designed to bind to complementary target RNA sequences via Watson-Crick base pairing [47] [48]. This binding allows researchers to precisely modulate RNA activity, protein expression, and cellular function. The emergence of the cell surface RNA field introduces new challenges and applications for ASO technology, requiring sophisticated delivery and analytical strategies to target and analyze these extracellular and membrane-associated RNAs effectively. This whitepaper provides an in-depth technical guide on deploying ASOs to modulate and study cell surface RNA activity, framing the discussion within the broader context of mapping the functional RNA surfaceome.

Antisense Oligonucleotide Technology: Core Principles

Mechanisms of Action for Functional Modulation

ASOs exert their effects through several distinct mechanisms, which can be strategically selected based on the desired experimental or therapeutic outcome. These mechanisms are broadly classified into those that lead to the degradation of the target RNA and those that modulate its function or expression without degradation.

Table 1: Mechanisms of Action of Antisense Oligonucleotides

Mechanism Category	Specific Mechanism	Molecular Process	Key ASO Features/Examples
Target RNA Degradation	RNase H1 Recruitment	Binds to target RNA, forming a DNA-RNA hybrid duplex. Recruits endogenous RNase H1, which cleaves the RNA strand [47] [48].	Requires a central "gap" of DNA nucleotides (e.g., in a gapmer design).
	RNA Interference (RNAi)	Double-stranded siRNAs are loaded into the RISC complex. The guide strand binds the target mRNA, leading to its cleavage by Ago2 [48].	siRNA; more stable duplex but challenging systemic delivery.
Functional Modulation (Non-Degradative)	Steric Hindrance	Binds to target RNA and physically blocks processes such as ribosomal scanning, translation initiation, or ribosome assembly [48].	Often uses high-affinity chemistries (e.g., PMO, 2'-MOE).
	Splicing Modulation	Binds to pre-mRNA sequences to mask splice sites or regulatory elements. Promotes either exon inclusion or exon skipping to alter the final protein product [48].	Used in Nusinersen (Spinraza) for spinal muscular atrophy.
	microRNA Inhibition	Binds to and sequesters mature miRNA, preventing it from interacting with its natural mRNA targets [48].	Single-stranded ASO; can alter expression of entire gene networks.

Essential Chemical Modifications

Unmodified oligonucleotides are highly susceptible to nuclease degradation and exhibit poor cellular uptake. Chemical modifications are therefore critical to enhancing the drug-like properties of ASOs.

• Backbone Modifications: Phosphorothioate (PS) is a first-generation modification where a non-bridging oxygen atom in the phosphate backbone is replaced with sulfur. This confers nuclease resistance, increases binding to plasma proteins (extending half-life), and improves cellular uptake [47].
• Sugar Modifications:
  • 2′-O-methyl (2′-O-Me) and 2′-O-methoxyethyl (2′-MOE): These modifications increase binding affinity to the target RNA, enhance nuclease resistance, and reduce immune stimulation [47].
  • Locked Nucleic Acid (LNA): Incorporates a methylene bridge between the 2' oxygen and 4' carbon of the ribose ring, dramatically increasing thermal stability (Tm) and potency [47].
• Morpholino and Neutral Backbones: Phosphorodiamidate Morpholino Oligomers (PMOs) replace the ribose sugar with a morpholine ring and use a phosphorodiamidate linkage. They are charge-neutral, resistant to nucleases, and function primarily through steric hindrance [47].
• Conjugations for Delivery: To facilitate delivery to specific tissues, ASOs are often conjugated to targeting ligands. The GalNAc (N-acetylgalactosamine) conjugate is a hallmark example, enabling highly efficient uptake by hepatocytes via the asialoglycoprotein receptor [49].

Figure 1: ASO Mechanisms for Modulating RNA Function. This diagram illustrates the primary pathways through which ASOs, upon binding their target RNA, can lead to either degradation of the RNA or functional modulation of its output.

Interrogating Cell Surface RNAs: Technical Approaches and Workflows

Targeting RNAs at the cell surface presents unique challenges, including accessibility, the specific identification of true surface RNA targets, and the need for specialized delivery and readout systems.

Identifying the Target: Surfaceome Interrogation

The first step is defining the "surfaceome"—the repertoire of RNAs present on the cell surface. RNA-seq is a powerful tool for this discovery phase.

• Surfaceome Database Mining: This computational approach involves comparing RNA-seq data from normal and abnormal cells (e.g., cancer cells vs. healthy counterparts) against a curated database of genes known or predicted to encode cell surface and secreted proteins [50]. By focusing on transcripts that are upregulated in the target cells, researchers can generate a shortlist of potential surface protein mRNAs, which may be co-regulated with or attached to surface RNAs.
• Workflow:
  • Cell Sorting: Isolate pure populations of target cells (e.g., leukemia initiating cells) using flow cytometry.
  • RNA Extraction & Sequencing: Prepare high-quality RNA for deep sequencing.
  • Bioinformatic Analysis: Map sequencing reads and calculate expression values (e.g., TPM - Transcripts Per Million).
  • Surfaceome Filtering: Cross-reference expressed genes with the surfaceome database to identify upregulated surface-associated transcripts (e.g., GPR56, CD53, CD59a in T-ALL models) [50].

Critical Controls for Surface RNA Validation

The emerging field of glycoRNA necessitates rigorous controls. A key concern is that standard RNA isolation methods (e.g., acidic phenol-chloroform) may co-purify non-RNA N-glycoconjugates that are resistant to RNase digestion. These can be mistakenly interpreted as glycoRNA [46].

• Proposed Control Experiment: After metabolic labeling with Ac4ManNAz and RNA isolation, split the sample.
  • Test Sample: Treat with RNase, then perform a silica column clean-up.
  • Control Sample: Perform the silica column clean-up first, then treat with RNase.
• Interpretation: A genuine glycoRNA signal should be lost in both workflows. If the signal is lost only in the first workflow (RNase before column), it may indicate the presence of a co-purifying, RNase-insensitive N-glycoconjugate that is being removed by the column's binding conditions, leading to a false positive [46].

Experimental Protocols for Functional Interrogation

Protocol: Functional Screening of ASOs Using Patient-Derived Organoids

This scalable platform allows for personalized ASO testing in a physiologically relevant model system [51].

Materials:

• Patient-derived cells or biopsy samples.
• Organoid culture media and Matrigel.
• Library of chemically modified ASOs (e.g., PS-backbone, 2'-MOE or LNA wings).
• Transfection reagent (e.g., lipid nanoparticles) or electroporation device.
• RNA extraction kit (e.g., TRIzol).
• qRT-PCR setup.
• Antibodies for surface protein detection (e.g., flow cytometry).

Method:

• Organoid Generation: Culture patient-derived cells in 3D Matrigel droplets with specialized media to promote self-organization into organoids. Expand organoids for 2-4 weeks.
• ASO Transfection:
  • Lipid Nanoparticle (LNP) Mediated Delivery: Formulate ASOs into LNPs and add to the organoid culture medium.
  • Electroporation: Dissociate organoids into single cells or small clusters, electroporate with ASOs, and re-plate in Matrigel.
• Incubation: Maintain transfected organoids for 48-96 hours to allow for target engagement and functional effect.
• Functional Readouts:
  • Molecular: Extract RNA and perform qRT-PCR to quantify target RNA levels.
  • Biochemical: Analyze protein expression from dissociated organoids via Western blot or flow cytometry.
  • Phenotypic: Monitor organoid morphology, viability, or biomarker expression (e.g., via immunofluorescence) for changes indicative of functional modulation.
• Validation: Confirm hits in secondary assays and orthologous models.

Protocol: Targeting Cell Surface RNA-Protein Interactions

This protocol uses ASOs to disrupt the interaction between a surface RNA (like a glycoRNA) and its binding partner.

Materials:

• Cells expressing the target surface RNA.
• Steric-blocking ASOs (e.g., PMO or 2'-MOE modified) designed to the interaction site.
• Ligand for the surface RNA (e.g., recombinant Siglec-Fc protein).
• Labeling reagent (e.g., fluorescent antibody against Fc fragment).
• Flow cytometer.

Method:

• ASO Design: Design ASOs to target the putative binding region of the glycoRNA for its receptor, based on structural prediction or empirical data.
• Cell Treatment: Transfect cells with the steric-blocking ASO or a scrambled control ASO. Include an untreated control.
• Ligand Binding Assay:
  • 48-72 hours post-transfection, harvest cells and wash.
  • Incubate cells with the recombinant ligand protein (e.g., Siglec-Fc) at a predetermined concentration in a FACS buffer for 30-60 minutes on ice.
  • Wash cells to remove unbound ligand.
  • Incubate with a fluorescently-labeled secondary antibody (e.g., anti-human IgG-AF488) for 30 minutes on ice.
  • Wash and resuspend cells in buffer.
• Analysis: Analyze cells by flow cytometry. A successful blockade by the ASO will result in a decrease in mean fluorescence intensity (MFI) compared to the control ASO groups, indicating reduced ligand binding to the cell surface.

The Scientist's Toolkit: Key Research Reagent Solutions

Table 2: Essential Reagents for ASO-based Cell Surface RNA Interrogation

Reagent / Solution	Function / Purpose	Example Specifics / Notes
Chemically Modified ASOs	Core therapeutic/functional agent; determines potency, stability, and mechanism.	Gapmers (RNase H1): PS-backbone with 2'-MOE/LNA wings. PMOs (Steric Block): Neutral backbone, ideal for splicing modulation and blocking [47] [48].
Metabolic Chemical Reporters (MCRs)	Label glycans on surface glycoRNAs for detection and isolation.	Ac4ManNAz: Converted to azido-sialic acids in cells, incorporated into glycans. Allows bioorthogonal click chemistry conjugation to biotin/fluorophores [46].
Lipid Nanoparticles (LNPs)	Formulate and deliver ASOs into cells and organoids.	Critical for hard-to-transfect primary cells and in vivo delivery. Composed of ionizable lipids, phospholipids, cholesterol, and PEG-lipids [49].
GalNAc Conjugation	Targeted delivery of ASOs to hepatocytes in vivo.	A trivalent GalNAc cluster conjugated to the ASO enables receptor-mediated uptake by the liver [49].
TRIzol / AGPC Reagent	Simultaneously isolate RNA, DNA, and protein from complex samples.	Acidic Guanidinium Thiocyanate-Phenol-Chloroform based. Caution: Can co-purify glycoconjugates; requires rigorous controls for glycoRNA work [46].
Click Chemistry Kit	Covalently link MCR-incorporated azide groups to detection tags.	Copper-free (SPAAC) kits are preferred for biological systems to avoid copper-induced toxicity. Used to attach biotin (for pulldown) or fluorophores (for imaging) [46].
Thevetiaflavone	Thevetiaflavone, MF:C16H12O5, MW:284.26 g/mol	Chemical Reagent
Syzalterin	Syzalterin, MF:C17H14O5, MW:298.29 g/mol	Chemical Reagent

Figure 2: Workflow for Functional Interrogation of Surface RNA. This diagram outlines the key stages in a project designed to target and validate the function of a cell surface RNA using ASOs.

The convergence of antisense technology with the nascent field of cell surface RNA biology opens a vast new territory for functional interrogation and therapeutic development. ASOs provide the precise, programmable scalpel needed to dissect the roles of specific glycoRNAs and other surface-associated RNAs. However, this potential is tempered by technical challenges, including the unambiguous verification of surface RNA targets and the development of efficient delivery systems that can reach these extracellular and membrane-associated sites beyond the liver.

Future progress will be driven by several key areas of innovation. Advanced Delivery Systems, such as novel nanoparticles and ligands targeting non-hepatic tissues, are crucial for expanding the therapeutic horizon. Improved Analytical Techniques that can definitively distinguish true glycoRNAs from co-purifying contaminants will be essential for building a reliable knowledge base. Finally, the integration of Artificial Intelligence in ASO design—predicting optimal sequences, off-target effects, and RNA secondary structure—will dramatically accelerate the discovery and validation process [52]. As these tools mature, the functional interrogation of cell surface RNAs with ASOs will move from a specialized research technique to a central pillar of drug discovery, enabling us to target previously inaccessible pathways and redefine the boundaries of therapeutic possibility.

Navigating Technical Complexities: Overcoming Challenges in maxRNA Research

Distinguishing True Surface Association from Cytoplasmic Contamination

The plasma membrane serves as the critical interface governing cellular communication, signal transduction, and response to extracellular cues. Recent investigations have revealed an unexpected population of RNAs at the cell surface, challenging traditional paradigms of RNA localization and function. However, distinguishing bona fide surface-associated RNAs from cytoplasmic contamination represents a formidable technical challenge that must be overcome to advance this emerging field. Accurate discrimination is paramount for understanding the full functional repertoire of RNA molecules, which may include direct roles in cell signaling, immune recognition, and surface-mediated pathologies. This technical guide provides researchers with a comprehensive framework for validating true surface association of RNAs through integrated methodological approaches and stringent validation criteria, framed within the broader context of elucidating the functional significance of cell surface RNA localization.

The Critical Importance of Surface RNA Validation

The plasma membrane represents a dynamic ecosystem comprising proteins, lipids, and emerging evidence suggests, specific RNA populations. Traditional subcellular fractionation methods frequently yield ambiguous results due to the inherent risk of cytoplasmic leakage during isolation procedures. False positives arising from cytoplasmic contamination can profoundly misdirect research conclusions and impede conceptual advances. Conversely, false negatives may cause researchers to overlook legitimate surface-localized RNAs with potentially novel functions.

Recent high-resolution mapping of the surface proteome has revealed unexpected protein complexes at the plasma membrane, including mitochondrial proteins such as TFAM, demonstrating the capacity for unconventional localization of biomolecules [53]. Similarly, RNAs traditionally considered strictly cytoplasmic or nuclear may localize to the cell surface through specific mechanisms. Technical approaches must therefore achieve three fundamental objectives: (1) preservation of membrane integrity during analysis, (2) selective accessibility to surface-exposed molecules, and (3) orthogonal validation through multiple complementary methodologies.

Methodological Framework for Surface RNA Detection

Controlled Permeabilization Approaches

Selective membrane permeabilization enables differential access to surface-exposed versus intracellular molecules, providing a powerful strategy for distinguishing localization.

Table 1: Permeabilization Agents and Their Applications

Agent	Mechanism	Application	Key Considerations
Digitonin	Cholesterol-selective detergent	Selective plasma membrane permeabilization	Concentration-dependent; cell type-specific cholesterol content affects efficiency
Saponin	Cholesterol-complexing agent	Reversible permeabilization	Milder than digitonin; suitable for sequential extraction
Streptolysin O	Cholesterol-dependent pore-forming toxin	Controlled access to cytoplasmic compartment	Large pore size; enables extraction of cytoplasmic components
Non-ionic detergents	Membrane lipid disruption	Complete cell lysis	Used for total RNA positive controls; concentrations critical

The fundamental principle involves using mild, controlled permeabilization to extract cytoplasmic content while preserving surface-associated molecules. Validation requires demonstrating absence of cytoplasmic markers in the surface-associated fraction.

Surface-Specific Proximity Labeling

Proximity labeling technologies enable selective tagging of molecules within defined subcellular compartments without physical separation. When adapted for surface RNA detection, these methods provide compelling evidence for true surface association.

Horseradish Peroxidase (HRP)-catalyzed labeling employs antibodies targeting surface proteins conjugated to HRP. In the presence of hydrogen peroxide, HRP converts biotin-phenol into phenoxyl radicals that tag proximal proteins and potentially RNAs within a 200-300 nm radius [53]. This approach has successfully mapped surface protein interactomes with high resolution, identifying functional nanodomains and unexpected protein associations.

Halo-seq represents an RNA-specific proximity labeling method that utilizes Halo-tagged proteins targeted to specific cellular compartments. Upon addition of a dibromofluorescein (DBF)-conjugated ligand, singlet oxygen generation tags proximal RNAs within approximately 100 nm upon light activation [54]. The tagged RNAs are then purified via click chemistry and analyzed by sequencing. While typically applied to intracellular compartments, Halo-seq can be adapted for surface studies by employing surface-targeted HaloTag fusion proteins.

Diagram 1: Halo-seq Workflow for Surface RNA Profiling

Enzymatic Protection Assays

The enzymatic protection assay leverages the impermeability of the plasma membrane to macromolecular enzymes. Surface-exposed RNAs are susceptible to degradation by added nucleases, while intracellular RNAs remain protected.

Protocol:

• Divide cell sample into aliquots: +Nuclease (experimental), -Nuclease (control), and Permeabilized +Nuclease (control for efficiency)
• Treat intact cells with RNase A (100 µg/mL final concentration) in PBS supplemented with Ca²⁺/Mg²⁺
• Incubate at 37°C for 30 minutes
• Add RNase inhibitor and harvest RNA
• Analyze target RNA levels by qRT-PCR or RNA-seq

True surface-associated RNAs will show significant degradation in the +Nuclease condition but remain intact in the -Nuclease control. The Permeabilized +Nuclease condition verifies complete RNA degradation when accessibility barriers are removed.

Flow Cytometry-Based RNA Detection

The PrimeFlow RNA assay enables simultaneous detection of RNA and protein markers at single-cell resolution, providing a powerful approach for correlating surface phenotype with RNA localization.

Workflow:

• Cell surface staining with fluorescently-labeled antibodies
• Fixation and permeabilization to preserve architecture while allowing probe access
• Hybridization with target-specific oligonucleotide probes (20-40 oligonucleotides)
• Signal amplification through sequential hybridization:
  • Pre-amplifier molecules hybridize to bound probes
  • Amplifier molecules hybridize to pre-amplifiers
  • Multiple label probes hybridize to amplifiers
• Flow cytometric analysis to correlate RNA signals with surface markers [55]

This approach successfully detected cytokine mRNAs (IL-2, IFN-γ) in T cell subsets while maintaining surface protein staining capabilities, demonstrating the method's utility for heterogeneous populations [55].

Diagram 2: PrimeFlow RNA Assay for Surface Protein and RNA Co-detection

Integrated Validation Framework

No single method definitively establishes surface localization; rather, convergence of evidence from multiple orthogonal approaches provides compelling validation.

Table 2: Orthogonal Validation Strategies for Surface RNA Localization

Method	Key Readout	Strength	Validation Criterion
Controlled Permeabilization	Differential extractability	Preserves native interactions	Surface-associated RNA resistant to mild extraction
Proximity Labeling	Spatial tagging	Defined molecular radius	Specific tagging with surface-targeted enzymes
Enzymatic Protection	Nuclease sensitivity	Direct accessibility measurement	Sensitivity in intact cells; protection in controls
Flow Cytometry RNA FISH	Single-cell visualization	Correlation with surface markers	Co-detection with surface proteins
Immunofluorescence with Surface Markers	Spatial co-localization	Visual confirmation	Apposition with validated surface proteins

Technical Considerations and Pitfalls

Membrane Integrity Assessment

Routine assessment of membrane integrity is essential throughout experiments. Incorporate impermeant viability dyes (e.g., propidium iodide, 7-AAD) to detect compromised membranes. For enzymatic protection assays, include controls for cytoplasmic marker RNA degradation to verify membrane integrity.

Specificity Controls

• Isotype controls for antibody-based targeting methods
• Competition experiments with unlabeled probes or antibodies
• Negative control cells lacking target RNA expression
• Multiple target regions for hybridization-based detection

Quantitative Considerations

True surface-associated RNAs may represent a small fraction of total cellular RNA. Ensure sufficient sensitivity and dynamic range in detection methods. Single-molecule RNA FISH provides the requisite sensitivity for low-abundance transcripts [56].

Advanced Applications and Research Implications

Validated surface RNA localization enables investigation of novel functional paradigms. Surface RNAs may function as direct signaling molecules, mediate cell-cell communication, or serve as disease biomarkers. Technical advances in single-molecule imaging now permit tracking RNA dynamics in live cells, revealing that RNA localization mechanisms can transcend cell morphology—the same regulatory elements that localize RNAs to neuronal axons also direct localization to the basal pole of epithelial cells [54] [56].

The unfolded protein response illustrates the dynamic nature of RNA localization, with endoplasmic reticulum-localized transcripts being efficiently recruited to cytosolic granules during stress [38]. Similar dynamics may occur at the cell surface under pathological conditions, suggesting surface RNA localization may be a regulated process with functional consequences.

The Scientist's Toolkit: Essential Research Reagents

Table 3: Key Reagent Solutions for Surface RNA Studies

Reagent/Category	Specific Examples	Function/Application
Proximity Labeling Enzymes	Horseradish Peroxidase (HRP), HaloTag, APEX2	Catalyzes spatial tagging of proximal biomolecules
Membrane Integrity Markers	Propidium iodide, 7-AAD, Trypan blue	Assess plasma membrane intactness
Permeabilization Agents	Digitonin, saponin, streptolysin O	Controlled access to subcellular compartments
Nucleases	RNase A, RNase I, Benzonase	Enzymatic protection assays; digest accessible RNA
Fixation Reagents	Paraformaldehyde, methanol	Preserve cellular architecture and localization
Click Chemistry Components	Biotin-azide, propargylamine, Cu(I) catalysts	Covalent tagging of oxidized nucleotides
Flow RNA Detection	PrimeFlow RNA assay, SmartFlare probes	Single-cell RNA detection with protein co-staining
Surface Protein Antibodies	CD45, HLA class I/II, T-cell receptor markers	Target proximity labeling; validate surface domains
Furowanin A	Furowanin A, MF:C25H26O7, MW:438.5 g/mol	Chemical Reagent

Distinguishing true surface association from cytoplasmic contamination requires a rigorous, multi-faceted methodological approach. By implementing controlled permeabilization strategies, proximity labeling technologies, enzymatic protection assays, and single-cell correlation methods, researchers can confidently validate surface-localized RNAs. As the field advances, these technical standards will ensure the reliable identification and characterization of surface RNAs, potentially revealing novel biological functions and therapeutic opportunities. The integration of these methods within a comprehensive validation framework provides a pathway for transforming our understanding of RNA localization and function at the cell surface.

Addressing RNA Stability and Low Abundance on the Cell Surface

The classical view of the cell surface is dominated by proteins and lipids. However, recent discoveries have established that RNA molecules, once thought to be exclusively intracellular, are present on the cell surface and play crucial functional roles. These cell surface RNAs face two fundamental challenges: extreme low abundance relative to the intracellular RNA pool, and environmental instability from extracellular nucleases. This technical guide examines the mechanisms that stabilize these rare RNA molecules and the advanced methodologies required for their study, framed within the broader context of understanding cell surface RNA biology and its therapeutic applications.

The discovery of glycoRNAs—RNA molecules modified with complex glycans and presented on the external surface of cells—has fundamentally expanded our understanding of the cell surface molecular landscape [57]. These glycoRNAs form structural domains with RNA-binding proteins (RBPs), creating a hybrid biomolecular platform that facilitates critical cellular processes including viral entry and the cellular uptake of cell-penetrating peptides [57]. This whitepaper provides researchers with the technical framework for studying these elusive molecules, addressing both fundamental biological mechanisms and state-of-the-art methodological approaches.

The Molecular Basis of Surface RNA Stability and Organization

Glycan Modification as a Stabilizing Mechanism

GlycoRNAs represent a distinct class of biomolecules where RNA serves as a template for glycosylation within the secretory pathway. The modified RNA base 3-(3-amino-3-carboxypropyl)uridine (acp3U) has been identified as a direct attachment site for N-glycans [57]. This covalent modification with complex glycans confers several critical stabilizing properties:

• Protection from ribonuclease degradation through steric hindrance and glycan shielding
• Anchoring to the plasma membrane via association with membrane microdomains
• Extended extracellular half-life enabling functional interactions

Table 1: Key Characteristics of Cell Surface RNA Species

RNA Type	Modification	Localization Mechanism	Primary Functions
GlycoRNA	N-linked glycans	Association with membrane domains	Cell-surface adhesion, CPP entry
RBP-Complexed RNA	Protein binding	RBP-membrane interactions	Signaling domains, molecular trafficking
seRNA	Engineered stability elements	Targeted degradation activation	Therapeutic delivery, cell-specific targeting

RNA-Binding Protein Domains as Stabilizing Platforms

RNA-binding proteins (RBPs) form organized domains on the cell surface that cluster with glycoRNAs and their RNA ligands [57]. Super-resolution microscopy reveals these domains exhibit a tessellated pattern with prototypic size distribution, segregating from classical surface markers like MHC-I [57]. Key RBPs identified on the cell surface include:

• Nucleolin (NCL): First discovered as a cell-surface protein in the 1990s, with demonstrated roles in cancer states and viral entry mechanisms [57]
• hnRNP-U: Present on the surface of living cells across multiple cell types [57]
• YBX1: Validated as a surface RBP through orthogonal molecular and imaging strategies [57]

The stability of surface RNA is maintained through RBP-RNA complex formation, which protects RNA from degradation and facilitates clustering into functional domains. These RBP-RNA complexes are organized into specific surface domains that are dependent on intact cell-surface RNA for their structural integrity [57].

Quantitative Analysis of Surface RNA and RBPs

Systematic analysis of cell surface RBPs has revealed their extensive presence across diverse cell types. Through aggregation of 48 RBP datasets (RBPomes) and intersection with surface proteomes identified by multiple methods including sulfo-NHS-SS-biotin labeling and periodate-mediated oxidation of glycans, researchers have defined a high-confidence set of 1,072 RBPs present on the cell surface [57].

Table 2: Quantitative Analysis of Surface RBP and RNA Dependencies

Experimental Perturbation	Target	Observed Effect	Functional Impact
Ribonuclease treatment	Surface RNA	Disruption of RBP clustering	Loss of functional domains
TAT CPP entry assay	Surface RNA	Reduced cellular uptake	Dependence on RNA for entry mechanism
Orthogonal validation	csRBPs	Confirmed surface localization	Across multiple cell types

The functional significance of surface RNA is demonstrated by the finding that the TAT-derived cationic cell-penetrating peptide requires intact cell-surface RNAs for cellular uptake [57]. This dependence on surface RNA highlights the critical functional role these molecules play beyond mere structural presence.

Experimental Methodologies for Surface RNA Analysis

Surface Proteomics and RBP Identification

The comprehensive identification of surface RBPs requires multiple orthogonal approaches to overcome the challenges of low abundance and potential contamination from intracellular components. The following methodologies have proven effective:

• Biotinylation of surface lysines using membrane-impermeable reagents like sulfo-NHS-SS-biotin
• Periodate-mediated oxidation of surface glycans to selectively label external glycoconjugates
• Controlled enzymatic degradation of surface components with verification of membrane integrity
• Orthogonal validation through multiple molecular and imaging strategies [57]

Advanced Imaging and Localization Techniques

Super-resolution microscopy approaches are essential for visualizing the nanoscale organization of surface RNA and RBPs:

• Structured Illumination Microscopy (SIM) for enhanced resolution of surface domains
• Stochastic Optical Reconstruction Microscopy (STORM) for nanoscale mapping of RNA-Protein complexes
• Immunofluorescence with validated surface-specific protocols to distinguish true surface localization from intracellular pools

These imaging techniques have revealed that csRBPs cluster with each other and away from classical surface markers like MHC-I, forming specialized functional domains [57].

Selectively Expressed RNA (seRNA) Technology

A novel approach for targeting and functionalizing specific cell types based on intracellular RNA signatures utilizes selectively expressed RNA molecules (seRNAs). These sophisticated constructs remain inactive in non-target cells but undergo activation through partial degradation only in preselected target cell types [58].

The seRNA architecture consists of nine functional modules:

• mRNA-Cap - Standard 5' cap structure
• 5' untranslated region (5'UTR) - Contains regulatory elements
• Antisense sequence (AS) - Complementary to target RNA
• IRES-blocking sequence (IB) - Prevents IRES function in non-target cells
• RNase inhibiting sequence (RI) - Protects downstream sequences
• Internal ribosomal entry site (IRES) - Enables cap-independent translation
• Effector encoding sequence - Therapeutic or diagnostic payload
• 3' untranslated region (3'UTR) - Regulatory elements for stability
• Poly-A tail - Standard mRNA tail structure [58]

In target cells, the formation of double-stranded RNA through sense-antisense interactions induces partial degradation of the seRNA, removing the IRES-blocking sequence while leaving downstream functional elements intact. This enables target-cell-specific translation of effector proteins without the need for surface markers [58].

Research Reagent Solutions for Surface RNA Studies

Table 3: Essential Research Reagents for Cell Surface RNA Investigation

Reagent/Category	Specific Examples	Function/Application
Surface Labeling Reagents	Sulfo-NHS-SS-biotin, Periodate	Selective labeling of surface molecules
Validation Antibodies	Anti-NCL, Anti-hnRNP-U, Anti-YBX1, Anti-DDX21	Detection of specific surface RBPs
Enzymatic Tools	Cell-impermeable RNases, Proteases	Controlled surface digestion
Imaging Reagents	HaloTag ligands, DBF conjugates	Proximity labeling and visualization
Functional Assay Tools	TAT CPP, Custom seRNA constructs	Testing surface RNA functionality
Sequencing Platforms	eCLIP, Halo-seq, RNA Bind-N-Seq	Mapping binding sites and interactions

Technical Approaches for Overcoming Low Abundance Challenges

Sensitivity Enhancement Strategies

The extreme low abundance of surface RNA necessitates specialized approaches for detection and analysis:

• Halo-seq proximity labeling: Technique that uses Halo-tagged proteins with dibromofluorescein (DBF) conjugates to generate oxygen radicals within ~100nm radius upon light exposure, selectively oxidizing and labeling proximal RNA molecules [21]
• Enhanced CLIP (eCLIP): Advanced crosslinking and immunoprecipitation protocols that significantly reduce adapter contamination and improve efficiency in identifying RBP binding sites [59]
• RNA Bind-N-Seq (RBNS): In vitro binding assay using recombinant purified RBPs and pools of random RNA oligonucleotides to identify RNA sequences and structural binding preferences [59]

Specificity Optimization Methods

Distinguishing true surface localization from intracellular contamination requires rigorous controls:

• Membrane integrity verification through lactate dehydrogenase (LDH) release assays and propidium iodide exclusion
• Competition experiments with excess unlabeled ligands to confirm specific binding
• Multiple orthogonal detection methods to minimize technique-specific artifacts

Future Directions and Therapeutic Applications

The emerging understanding of surface RNA biology opens transformative therapeutic opportunities. The seRNA platform technology demonstrates how intracellular RNA signatures can be leveraged for precise cell targeting without reliance on surface markers [58]. Proof-of-concept studies have effectively treated breast tumor cell clusters in mixed cell systems and reduced U87 glioblastoma cell clusters in mouse brains without detectable side effects [58].

Future applications may include:

• Disease-specific targeting of cancer cells based on internal RNA fingerprints
• Modular therapeutic platforms that combine detection and effector functions
• Combinatorial targeting approaches that address tumor heterogeneity
• Diagnostic applications through surface RNA biomarker detection

The mechanistic understanding of how surface RNAs stabilize and function provides a foundation for engineering novel biological tools and therapeutics that exploit this previously unrecognized layer of cellular organization.

The challenges of RNA stability and low abundance on the cell surface are addressed through a combination of natural biological mechanisms and advanced technological approaches. Glycan modifications, RBP complex formation, and engineered stability elements work in concert to maintain functional RNA molecules in the demanding extracellular environment. Methodological innovations in detection, imaging, and analysis now enable researchers to overcome the technical barriers that have historically limited investigation in this field. As our understanding of surface RNA biology deepens, so too will our ability to harness these mechanisms for therapeutic intervention and diagnostic innovation, ultimately advancing the broader field of RNA-based medicine.

Optimizing Probe Design and Hybridization Conditions for Surface-FISH

Recent advances in RNA biology have revealed a surprising new topology for RNA molecules: the cell surface. The discovery of extracellular and cell surface-associated RNAs, including glycosylated RNA (glycoRNA), has established an entirely new environment for studying RNA biology and its functional implications [60]. This revelation opens novel avenues for basic research, diagnostic applications, and therapeutic development, particularly for targeting specific cell populations without requiring internalization.

Surface-FISH (Fluorescence In Situ Hybridization) represents a specialized adaptation of traditional FISH techniques designed to detect these extracellular RNAs while preserving membrane integrity and cellular viability. This technical guide provides a comprehensive framework for optimizing Surface-FISH protocols, with particular emphasis on probe design, hybridization conditions, and experimental validation specifically tailored for the unique challenges of detecting RNA on the cell surface.

Critical Considerations for Surface-FISH Probe Design

Effective Surface-FISH probe design must balance specificity, sensitivity, and accessibility to target sequences presented on the cell exterior. Unlike conventional intracellular FISH, Surface-FISH probes must hybridize to targets without membrane permeabilization, requiring specialized design strategies.

Thermodynamic and Specificity Optimization

The TrueProbes software platform represents a significant advancement in FISH probe design by integrating genome-wide BLAST-based binding analysis with thermodynamic modeling to generate high-specificity probe sets [61]. This approach addresses key limitations of conventional tools through:

• Comprehensive off-target assessment: Evaluation of probe specificity across the entire genome to minimize non-specific binding
• Binding affinity prediction: Computational modeling of hybridization efficiency under specified experimental conditions
• Structural constraint integration: Accounting for RNA secondary structure that may influence probe accessibility

For Surface-FISH applications, additional consideration must be given to the potential masking of target sequences by glycans or membrane proteins, which may necessitate targeting regions with predicted higher accessibility.

Probe Design Parameters for Microbial Targeting

DNA-FISH probe development for microbial identification provides valuable insights for Surface-FISH optimization. A novel DNA-FISH probe for Candida albicans detection achieved 98.9% hybridization efficiency with a fluorescence intensity of 25,000 (a.u.) while demonstrating minimal cross-reactivity with non-target microorganisms (4.7% for C. krusei, 2.3% for S. cerevisiae, and 1.9% for W. anomalus) [62].

Key design parameters for species-specific probes include:

• Sequence selection: Targeting the 26S ribosomal RNA gene for microbial identification
• In silico validation: BLASTN analysis for specificity confirmation and mathFISH simulations for performance prediction
• Probe properties optimization: Molecular weight, melting temperature, GC content, and self-complementarity calculations

Table 1: Key Performance Metrics for Optimized FISH Probes

Parameter	Traditional FISH Probe	Optimized Surface-FISH Target	Measurement Method
Hybridization Efficiency	Varies with formamide concentration	>98% (in buffer)	Flow cytometry (flow-FISH)
Specificity	Often requires cross-validation	<5% non-target binding	Comparison to non-target organisms
Fluorescence Intensity	Protocol-dependent	~25,000 a.u.	Standardized fluorescence units
Formamide Requirement	Often 10-20%	0%	Elimination of toxic denaturant

Hybridization Condition Optimization

Hybridization conditions fundamentally influence Signal-to-Noise Ratio in Surface-FISH experiments. The following parameters require systematic optimization:

Formamide-Free Hybridization

Conventional FISH protocols frequently employ formamide (10-20% v/v) to control stringency, but this carcinogenic denaturant poses safety concerns and may compromise cell viability [62]. Recent advances demonstrate that formamide-free hybridization is achievable through:

• Probe length optimization: Shorter probes (15-25 nt) for reduced stability without denaturants
• Temperature control: Precise thermal regulation during hybridization
• Ionic strength modulation: Adjustment of monovalent and divalent cation concentrations
• Competitor DNA inclusion: Using Cot-1 DNA or yeast tRNA to block non-specific binding

The successful development of a DNA-FISH probe for Candida albicans that functions with 0% formamide while maintaining high specificity demonstrates the feasibility of this approach for Surface-FISH applications [62].

Experimental Workflow for Surface-FISH

The following diagram illustrates the comprehensive workflow for Surface-FISH experiments, from probe design to image analysis:

Quantitative Assessment of Hybridization Conditions

Table 2: Optimization Parameters for Surface-FISH Hybridization Conditions

Parameter	Standard Range	Surface-FISH Considerations	Performance Impact
Temperature	37-46°C	Lower range to preserve membrane integrity	Critical for specificity; ±2°C can significantly alter signal
Time	2-16 hours	Balance between signal intensity and cell viability	Longer incubation increases signal but may reduce viability
Probe Concentration	1-50 ng/μL	Higher concentrations may improve surface accessibility	Excessive concentration increases background noise
Salt Concentration	0.1-0.9 M NaCl	Optimize for membrane stability	Affects stringency and hybridization kinetics
pH	7.0-8.0	Maintain physiological range	Significant deviation can compromise cell viability
Competitor DNA	0.1-2 μg/μL	Essential for reducing non-specific binding	Critical for signal-to-noise ratio in complex samples

Experimental Protocols and Methodologies

Flow-FISH Protocol for Quantitative Assessment

Coupling Surface-FISH with flow cytometry (flow-FISH) enables robust quantification and high-throughput application. The following protocol adapts established flow-FISH methods for surface RNA detection:

Day 1: Sample Preparation

• Cell Harvesting: Collect cells using gentle dissociation methods to preserve surface integrity
• Viability Assessment: Determine viability via trypan blue exclusion (>95% recommended)
• Fixation (optional): If required, use mild paraformaldehyde (1-2% for 10 min) followed by PBS washes
• Blocking: Incubate with blocking buffer (1% BSA in PBS) for 30 min at 4°C

Day 1: Hybridization

• Probe Mixture Preparation:
  • Surface-FISH probes: 5-20 ng/μL in hybridization buffer
  • Competitor DNA: 1 μg/μL Cot-1 DNA
  • tRNA: 0.1 μg/μL yeast tRNA
• Hybridization: Apply probe mixture to cells, incubate 4-16 hours at 37-42°C in dark humid chamber
• Stringency Washes:
  • First wash: 2× SSC/0.1% SDS for 15 min at hybridization temperature
  • Second wash: 1× SSC for 10 min at room temperature
  • Final rinse: 0.5× SSC for 5 min at room temperature

Day 1: Flow Cytometry Analysis

• Resuspension: Resuspend cells in PBS with viability marker (e.g., 1 μg/mL DAPI)
• Data Acquisition: Analyze using standard flow cytometer with appropriate laser lines for fluorophores
• Gating Strategy: Gate on viable single cells, then analyze fluorescence in probe channel

Image-Based Surface-FISH Protocol

For spatial resolution of surface RNA localization, the following protocol optimizes signal detection while maintaining cellular architecture:

Sample Preparation

• Cell Culture: Plate cells on appropriate imaging substrate (glass coverslips or chambered slides)
• Live-Cell Staining: Perform hybridization with cells in physiological buffer
• Viability Maintenance: Conduct procedures at 37°C with 5% COâ‚‚ if possible

Hybridization and Imaging

• Probe Application: Add probes diluted in optimized hybridization buffer directly to culture medium
• Real-Time Monitoring (optional): Image hybridization kinetics using time-lapse microscopy
• Fixation (post-hybridization): If required, fix after hybridization to preserve spatial relationships
• Mounting: Use anti-fade mounting medium for fluorescence preservation
• Image Acquisition: Acquire z-stacks using high-resolution microscopy (e.g., confocal or super-resolution)

Image Analysis Tools like FISH-quant v2 provide specialized analysis for single-molecule FISH data, offering:

• Automated spot detection: Identification of individual RNA molecules [63]
• Spatial quantification: Analysis of RNA distribution patterns relative to cell membrane
• Heterogeneity assessment: Measurement of cell-to-cell variability in surface RNA expression [64]

The Scientist's Toolkit: Essential Research Reagents

Table 3: Essential Research Reagents for Surface-FISH Experiments

Reagent/Category	Specific Examples	Function/Purpose	Optimization Notes
Probe Design Tools	TrueProbes, DECIPHER, mathFISH	In silico probe design and validation	Genome-wide specificity checking essential for surface targets [61] [62]
Fluorophores	DY488, DY549P1, DY647P1, Quasar dyes	Signal generation	Photostability critical for time-course experiments [65] [66]
Competitors	Cot-1 DNA, yeast tRNA	Block non-specific binding	Essential for reducing background in complex samples [65]
Hybridization Buffers	Dextran sulfate, SSC, formamide-free formulations	Reaction medium for hybridization	Commercial formulations available or custom preparation [65]
Image Analysis Software	FISH-quant v2, Big-FISH, QuantISH	Signal quantification and localization	Modular Python-based packages preferred for customization [63] [64]
Detection Instruments	Flow cytometers, confocal microscopes, super-resolution systems	Signal detection and visualization	Vutara VXL SMLM optimal for single-molecule resolution [66]

Troubleshooting and Quality Control

Common Challenges and Solutions

• High Background Signal: Increase stringency washes, optimize competitor DNA concentration, verify probe specificity
• Low Signal Intensity: Increase probe concentration, extend hybridization time, verify target accessibility
• Cell Viability Issues: Reduce hybridization temperature, shorten protocol duration, use physiological buffers
• Inconsistent Results Between Replicates: Standardize cell culture conditions, ensure consistent probe aliquoting, control hybridization temperature precisely

Validation Methodologies

• Specificity Controls: Include non-targeting scrambled probes, compete with unlabeled probes, test on knockout cells
• Sensitivity Assessment: Determine limit of detection using synthetic RNA spikes or cells with known expression levels
• Reprodubility Evaluation: Perform technical and biological replicates to establish coefficient of variation

Surface-FISH represents a powerful methodology for investigating the emerging biology of cell surface RNAs. Through optimized probe design, careful hybridization condition selection, and appropriate detection strategies, researchers can reliably detect and quantify RNAs present on the exterior of cells. This technical capability opens new possibilities for basic research into the functions of surface RNAs, development of diagnostic applications targeting specific cell types, and creation of therapeutic approaches that leverage surface RNA detection.

The continued refinement of Surface-FISH methodologies will undoubtedly yield further insights into the roles of surface RNAs in cellular communication, immune recognition, and disease pathogenesis, ultimately contributing to the expanding toolkit for spatial transcriptomics and single-cell analysis.

Mitigating Background Noise and Ensuring Specificity in Proximity Labeling Data

Proximity labeling (PL) has emerged as a revolutionary technique for mapping molecular interactions in living systems, offering unprecedented capabilities for identifying protein-protein interactions and spatial proteomes under near-physiological conditions [67]. In the specific context of cell surface RNA localization research—a field gaining significant attention with the discovery of surface-bound glycoRNAs and other extracellular RNA species—PL techniques enable researchers to capture transient interactions and define molecular landscapes that traditional methods often miss [9]. However, the utility of PL data depends entirely on the ability to distinguish specific interactions from non-specific background, a challenge that becomes particularly pronounced when studying delicate surface interactions and rare RNA species.

The growing recognition of RNA's presence on the cell surface, including findings that "a significant amount of RNA was associated with the cell surface during cell culture" and that these RNAs can influence cellular processes like growth and migration, underscores the need for highly specific molecular mapping tools [9]. This technical guide provides comprehensive strategies for mitigating background noise and ensuring specificity in proximity labeling experiments, with particular emphasis on applications in cell surface RNA research.

Proximity Labeling Techniques: Mechanisms and Noise Profiles

Proximity labeling employs engineered enzymes fused to a protein of interest (POI) that catalyze the covalent tagging of nearby proteins with a biotin substrate. These biotinylated proteins are subsequently enriched using streptavidin-coated beads and identified via mass spectrometry, enabling detailed mapping of protein interaction networks within their native cellular environment [67]. The field has developed several major PL systems, each with distinct mechanisms and operational parameters.

BioID, the first widely adopted PL system, utilizes a mutated E. coli biotin ligase (BirA) that leaks a reactive biotin-AMP intermediate into its surroundings. Proteins within approximately 10 nm become biotinylated on lysine residues. While BioID preserves the native subcellular environment, it requires long biotin incubation times (18-24 hours) and may suffer from steric hindrance due to its relatively large size [67]. BioID2, a smaller optimized variant, minimizes interference with target protein structure but still requires several hours for robust biotin labeling and has been reported to struggle with accurately detecting neuron-specific interactions [67].

APEX (and its enhanced version APEX2) utilizes the oxidative activity of a peroxidase to oxidize substrates like biotin-phenol in the presence of hydrogen peroxide, generating reactive radicals that covalently label nearby proteins within minutes. This rapid kinetics makes APEX ideal for capturing transient interactions, and its ability to produce electron-dense precipitates facilitates electron microscopy studies. However, the required hydrogen peroxide may induce oxidative stress and cause cytotoxic effects [67].

TurboID, created through directed evolution to enhance catalytic activity, can label proximal proteins within minutes, making it excellent for capturing rapid or dynamic interactions. Its enhanced reactivity, however, can lead to unintended over-labeling and increased background, requiring careful calibration to avoid adversely affecting cell viability [67]. Split-TurboID further refines this approach by splitting the enzyme into two halves, each fused to a different POI. Proximal proteins are labeled only when the two fragments reconstitute through physical interaction, enabling highly specific mapping of PPIs even at organelle contact sites, though this approach adds experimental complexity [67].

Technical Comparison of PL Systems

Table 1: Comparison of Major Proximity Labeling Systems

System	Enzyme Source	Labeling Time	Spatial Resolution	Key Advantages	Primary Noise/Background Concerns
BioID	Mutated E. coli biotin ligase (BirA)	18-24 hours	~10 nm	Works in many cellular compartments; physiological conditions	Lengthy labeling time captures indirect interactions; steric hindrance
BioID2	Optimized BirA variant	Several hours	~10 nm	Smaller size minimizes steric effects	Struggles with neuron-specific interactions; still requires hours of labeling
APEX/APEX2	Peroxidase	Minutes	<20 nm	Ultra-fast labeling captures transients; EM compatibility	Hydrogen peroxide causes cellular stress; potential cytotoxicity
TurboID	Evolved biotin ligase	Minutes	~10 nm	Extremely rapid labeling; high sensitivity	High background from over-labeling; cell stress at high expression
Split-TurboID	Split TurboID fragments	Minutes (upon reconstitution)	<10 nm	Extremely high specificity; minimal background	Complex experimental setup; requires optimization of fragment expression

Endogenous Biotinylated Proteins

A significant source of background in biotin-based PL techniques comes from endogenously biotinylated proteins, such as carboxylases in mitochondria, which generate strong signals that can obscure specific interactions [67]. These proteins are efficiently captured by streptavidin purification alongside truly biotinylated targets, complicating data analysis.

Mitigation Strategy: In Caenorhabditis elegans, this issue was successfully addressed by genetically tagging major endogenous biotinylated carboxylases with a His-tag, enabling their selective removal via Ni-based purification [67]. Similarly, antibody-based depletion methods can be employed in mammalian systems to remove common endogenous biotinylated proteins prior to streptavidin enrichment. Additionally, incorporating a pre-clearing step with streptavidin beads before the biotinylation reaction can reduce background from pre-existing biotinylated proteins.

Non-Specific Biotinylation

Non-specific biotinylation can occur through multiple mechanisms, including enzyme leakage into subcellular compartments, basal enzyme activity in the absence of true interactions, and diffusion of reactive biotin intermediates beyond the intended labeling radius [67]. This is particularly problematic when studying weak interactions or low-abundance proteins at the cell surface.

Mitigation Strategy: Careful optimization of labeling time and biotin concentration is essential. TurboID exhibits markedly higher catalytic activity and achieves rapid biotinylation within minutes, but this enhanced efficiency can cause elevated background labeling [67]. Parameters must be tuned based on the specific subcellular environment. Furthermore, comparing samples within the same cellular compartment using localization-matched controls helps distinguish specific labeling from background. Quantitative proteomic approaches, such as tandem mass tag-based labeling, can further refine data interpretation through normalization [67].

Non-Specific Adsorption in Cell Surface Studies

Research on cell surface molecules presents unique challenges regarding non-specific binding. Nucleic acids are polyanions that can non-specifically bind to positively charged molecules or regions on the surface of live cells [9]. This is especially relevant when studying cell surface RNA or RNA-binding proteins.

Mitigation Strategy: Competitive inhibition with non-specific nucleic acids has proven effective. In studies of cell surface nucleic acids, adding excess herring sperm DNA (HS-DNA) at 0.1 mg mL⁻¹ successfully inhibited non-specific binding of DNA probes to cell surfaces [9]. Similarly, using tRNA as a competitor can reduce non-specific RNA interactions. The application of anionic dyes like ANS (1-anilinonaphthalene-8-sulfonate) can help characterize surface charge density between different cell lines, informing the extent of competitive inhibitor needed [9].

Advanced Strategies for Enhancing Specificity

Peptide-Level Enrichment

Traditional protein-level enrichment methods often co-purify unlabeled peptides or proteins that are indirectly associated with labeled targets, leading to potential false positives. Although negative controls and fold-change calculations offer a practical means of reducing background noise, this statistical approach has inherent limitations in distinguishing true interactors from nonspecifically bound proteins [67].

Mitigation Strategy: Recent studies have moved toward peptide-level enrichment, which allows direct identification of biotinylation sites and enhances confidence in PPI data [67]. This site-specific information provides strong evidence that the protein was truly labeled in situ, eliminates the need for negative control-based fold-change calculations, and offers unique advantages such as the ability to infer membrane protein topology and improve the detection of low-abundance proteins that might be masked in protein-level approaches. While peptide-level analysis requires more careful sample preparation and is technically more demanding, its higher specificity and clearer interpretation make it a superior alternative for improving the accuracy of PL-based proteomics [67].

Experimental Design and Control Strategies

Proper experimental design with appropriate controls is fundamental for distinguishing specific interactions from background.

Essential Controls:

• Expression control: Express the PL enzyme alone without fusion to your POI to identify background from enzyme expression.
• Catalytic dead control: Use a catalytically inactive mutant of the PL enzyme fused to your POI.
• Subcellular localization control: Use a localization-matched control that targets the same compartment but should not interact with your proteins of interest.
• Biotin-free control: Process samples without biotin addition to identify background binding to streptavidin beads.

Experimental Replication and Quantification: Incorporating biological replicates and quantitative mass spectrometry methods (e.g., TMT, SILAC, or label-free quantification) enables statistical assessment of interaction specificity and significantly improves reliability of identified interactions.

Optimization for Cell Surface RNA Research

When applying PL to study cell surface RNA localization and its associated proteins, several specific considerations apply. RNase treatment controls are essential; as demonstrated in cell surface RNA studies, treatment with RNase A can remove surface-bound RNA and significantly alter the binding profile of DNA probes [9]. This approach can validate RNA-dependent interactions in PL experiments.

Additionally, since cell surface RNA research often involves membrane proteins and delicate surface interactions, gentle lysis conditions that preserve membrane integrity while maintaining labeling efficiency are crucial. Combining PL with subsequent RNA-protein crosslinking techniques (such as PAR-CLIP) can provide orthogonal validation of identified RNA-protein interactions.

Workflow Visualization: Ensuring Specificity in Proximity Labeling

Diagram 1: Specificity-Focused Proximity Labeling Workflow

Quantitative Data Presentation: Noise Mitigation Techniques

Table 2: Quantitative Comparison of Background Reduction Techniques

Technique	Background Reduction Efficacy	Technical Difficulty	Cost Impact	Suitable For	Limitations
Competitive inhibition (HS-DNA)	High (≥80% reduction in non-specific binding) [9]	Low	Low	Cell surface studies; charged environments	May interfere with some specific interactions
Peptide-level enrichment	High (direct site identification) [67]	High	Medium	All PL applications; membrane proteins	Technically demanding; requires expertise
Genetic tagging of endogenous biotinylated proteins	Very high (specific removal) [67]	Medium-High	Medium	Model organisms; scalable systems	Limited to genetically tractable systems
Split-TurboID	Highest (requires physical interaction) [67]	High	Medium	Direct PPI mapping; organelle contacts	Complex optimization; may miss some interactions
Optimized labeling time	Medium (context-dependent) [67]	Low	None	All applications; especially TurboID	Requires extensive optimization for each system
RNase treatment controls	High for RNA-dependent interactions [9]	Low	Low	RNA-related studies; cell surface work	Cannot distinguish direct vs. indirect RNA binding

The Scientist's Toolkit: Essential Reagents for Specific Proximity Labeling

Table 3: Essential Research Reagents for High-Specificity Proximity Labeling

Reagent/Category	Specific Function	Considerations for Cell Surface RNA Research
TurboID/BioID2 plasmids	Engineered biotin ligases for efficient labeling	Select promoters appropriate for your cell system; consider inducible systems
Herring Sperm DNA (HS-DNA)	Competitive inhibitor for non-specific nucleic acid binding	Use at 0.1 mg mL⁻¹ to inhibit non-specific binding [9]
Streptavidin magnetic beads	Enrichment of biotinylated proteins	Compare different bead materials for efficiency; test binding capacity
Mass spectrometry-grade trypsin	Protein digestion for peptide-level analysis	Essential for peptide-level enrichment strategy [67]
Anti-biotin antibodies	Validation of biotinylation efficiency	Useful for Western blot and immunofluorescence confirmation
RNase A	Control for RNA-dependent interactions	Treatment can confirm RNA-mediated interactions [9]
Protease inhibitors	Preserve protein complexes during lysis	Essential for maintaining delicate interactions at cell surface
Crosslinkers (e.g., formaldehyde)	Stabilize transient interactions	Use mild concentrations to avoid artifact formation
Cell surface biotinylation reagents	Orthogonal validation of surface localization	Confirm surface localization of identified proteins
Membrane-permeable vs. impermeable biotin	Distinguish intracellular vs. surface labeling	Crucial for specifically studying cell surface interactions

Mitigating background noise and ensuring specificity in proximity labeling represents both a technical challenge and a requirement for generating biologically meaningful data, particularly in the emerging field of cell surface RNA research. By implementing the systematic approaches outlined in this guide—including careful system selection, strategic controls, peptide-level enrichment, and field-specific optimizations—researchers can significantly enhance the reliability of their proximity labeling data. As the field continues to evolve with new enzymes, methods, and computational approaches, the principles of rigorous validation and noise management will remain fundamental to extracting true biological insights from proximity labeling experiments.

From Specificity to Therapy: Validating maxRNA Function and Therapeutic Potential

The localization and function of RNA molecules have traditionally been studied within the confines of the cell nucleus and cytoplasm. However, emerging research has revealed a more complex and dynamic picture, with specific RNAs, including glycoRNAs, present on the outer cell surface, where they play pivotal roles in cell signaling and immune processes [18]. Understanding the mechanisms that govern RNA localization and its functional consequences requires a context-specific approach, particularly across different cell types and environmental conditions. This technical guide explores how maxRNA profiles—comprehensive RNA expression and localization signatures—serve as functional identifiers across various cell types, with a specific focus on Peripheral Blood Mononuclear Cells (PBMCs). We frame this discussion within a broader thesis on cell surface RNA, emphasizing its potential impact on immune regulation, disease mechanisms, and therapeutic development.

The Context-Specific Nature of RNA Expression and Localization

Widespread, Context-Specific Gene Regulation in Immune Cells

Single-cell RNA-sequencing (scRNA-seq) of PBMCs from 120 individuals exposed to different pathogens (C. albicans, M. tuberculosis, and P. aeruginosa) has demonstrated that gene expression regulation is highly context-specific [68]. The study analyzed over 1.3 million cells, revealing that cellular environment and genetic background significantly influence how genetic variants affect gene expression.

Key Quantitative Findings from PBMC scRNA-seq: [68]

Analysis Factor	Finding	Quantitative Result
Cell-Type Specificity	More prominent factor than pathogen-specificity	N/A
Differential Expression (DE)	Myeloid cells (monocytes, DCs) showed highest number of DE genes	688–2022 DE genes after 3h; 1052–2616 after 24h
Differential Expression (DE)	T cells (CD4+, CD8+) showed fewest DE genes	688–2022 DE genes after 3h; 1052–2616 after 24h
DE Gene Sharing	Cell-type-specific DE genes	31.1% of 5516 unique DE genes
DE Gene Sharing	DE genes shared across all major cell types	15.1% of 5516 unique DE genes
DE Gene Sharing	Sharing between different pathogens (same timepoint)	39.8% of total unique DE genes
DE Gene Sharing	Sharing between different timepoints (same pathogen)	10.3% of total unique DE genes
Genetic Regulation	Monocyte response QTLs affecting co-expression	71.4% of genetic variants

The data indicates that the immune response was more specific to the timepoint after stimulation than to the type of pathogen, suggesting that the genetic control of responsive genes is more time-dependent than pathogen-dependent [68].

Conserved RNA Localization Mechanisms Across Cell Morphologies

Beyond expression levels, the subcellular localization of RNA is a critical layer of post-transcriptional regulation. Research has demonstrated that the molecular mechanisms governing RNA localization can transcend vastly different cell morphologies [54]. For instance, RNA regulatory elements and RNA-binding proteins (RBPs), such as LARP1, that localize mRNAs to neuronal axons also direct the same mRNAs to the basal pole of intestinal epithelial cells [54]. This suggests the existence of conserved, predictable principles for RNA localization, where the destination is defined by generalizable instructions related to cellular architecture rather than a specific anatomical name like "axon" [54].

Experimental Profiling of maxRNA Signatures

Detailed scRNA-seq Protocol for PBMC Profiling

The following methodology outlines the experimental workflow for generating maxRNA profiles from PBMCs, as described in the 1M-scBloodNL study [68].

1. Sample Preparation and Stimulation:

• Source: PBMCs are isolated from 120 individuals.
• In Vitro Stimulation: Cells are exposed to pathogens like C. albicans (CA), M. tuberculosis (MTB), or P. aeruginosa (PA).
• Time Course: Profiles are generated from unstimulated cells and after 3-hour and 24-hour stimulations.

2. Single-Cell RNA Sequencing:

• Technology: 10x Genomics scRNA-seq (using both v2 and v3 chemistry reagents).
• Cell Capture: An average of 1,226 cells are captured per individual per condition.
• Gene Detection: An average of 907 genes/cell (v2) and 1,861 genes/cell (v3) are detected.

3. Data Processing and Quality Control:

• Doublet Identification: Souporcell is used to identify doublets from different individuals (average of 12.0% doublets).
• Sample Demultiplexing: Demuxlet is used to assign cells to individual samples.
• Quality Control: Low-quality cells are excluded based on chemistry-specific QC thresholds, resulting in a final dataset of 928,275 cells.

4. Cell Type Identification:

• Dimensionality Reduction: UMAP is applied to normalized, integrated count data.
• Clustering: KNN-clustering identifies six main cell types: B cells, CD4+ T cells, CD8+ T cells, monocytes, natural killer (NK) cells, and dendritic cells (DCs).
• Sub-cell Type Classification: Major types are further subdivided (e.g., naïve and memory T cells, classical and non-classical monocytes).

5. Differential Expression and QTL Analysis:

• DE Analysis: Performed using MAST in each major and sub-cell type.
• QTL Mapping: Expression QTL (eQTL), co-expression QTL (co-expression QTL), and response QTL (response QTL) analyses are conducted to understand genetic regulation.

Visualizing the Experimental and Analytical Workflow

The following diagram, created with Graphviz, outlines the core experimental and computational pipeline for establishing maxRNA profiles.

Diagram 1: Workflow for maxRNA profiling in PBMCs.

The following table details key research reagents and computational tools essential for conducting scRNA-seq studies and analyzing maxRNA profiles.

Table: Research Reagent Solutions for maxRNA Profiling

Item Name	Function / Application	Specific Example / Note
10x Genomics Chromium	High-throughput scRNA-seq platform	Used for capturing ~1,226 cells/individual/condition; v2 and v3 chemistries offer different gene detection sensitivities [68].
Souporcell	Computational tool for doublet detection	Identifies droplets containing cells from more than one individual [68].
Demuxlet	Computational tool for sample demultiplexing	Genetically assigns single-cell data to individual donors in a pooled experimental design [68].
MAST	R package for differential expression analysis	Used for identifying context-specific gene expression changes in scRNA-seq data [68].
Halo-seq	Proximity labeling technique for RNA localization	Maps transcriptome-wide RNA spatial distributions using a Halo-tagged protein and photo-activatable labeling [54].
C2bbe1 Cell Line	Model for human intestinal enterocytes	Polarized monolayers used to study RNA localization across the apicobasal axis [54].

Pathway and Regulatory Logic Diagrams

Context-Specific Genetic Regulation Pathway

The following diagram illustrates the discovered pathway through which genetic variation influences context-specific gene expression and co-expression in immune cells, potentially contributing to disease risk.

Diagram 2: Logic of context-specific genetic regulation.

Conserved RNA Localization Logic

This diagram summarizes the finding that RNA localization mechanisms are conserved across different cell morphologies, based on the interaction between specific RNA elements and RNA-binding proteins.

Diagram 3: Conserved logic of RNA localization.

The integration of large-scale scRNA-seq datasets, as exemplified by the PBMC study, with mechanistic insights into RNA localization provides a powerful framework for defining maxRNA profiles. These profiles are not static but are dynamic functional signatures shaped by cellular context, genetic background, and environmental exposures. The discovery that fundamental RNA localization rules are conserved across cell types further suggests that maxRNA profiles can be predictive [54]. This comprehensive understanding, bridging cell surface RNA biology [18] with detailed cellular maps of gene regulation [68], opens new avenues for deciphering immune function, disease etiology, and the development of novel diagnostic and therapeutic strategies.

The subcellular localization of messenger RNA (mRNA) represents a crucial post-transcriptional regulatory mechanism that enables polarized cells to create distinct local proteomes, thereby facilitating specialized cellular functions. While neurons and epithelial cells exhibit dramatically different morphologies and physiological roles, emerging evidence demonstrates that the fundamental mechanisms governing RNA localization transcend these morphological boundaries. The mechanistic conservation of RNA localization codes between these diverse cell types reveals an underlying organizational principle of cellular polarity that operates through shared molecular players, including specific RNA-binding proteins (RBPs), cis-regulatory elements, and motor proteins [54]. This conservation is not merely structural but functional, as localized translation enables both axon guidance in neurons and nutrient processing in intestinal epithelia through remarkably similar molecular pathways. The discovery that the same RNA elements and RBPs regulate localization in both neuronal projections and the basal pole of epithelial cells suggests the existence of a universal "RNA localization code" that is adaptable across cellular contexts [54]. This technical analysis examines the conserved mechanisms, experimental evidence, and functional implications of shared RNA localization pathways in neuronal and epithelial systems, providing researchers with a comprehensive framework for understanding and investigating this fundamental biological process.

Fundamental Mechanisms of RNA Localization

RNA localization is achieved through several conserved mechanisms that operate across diverse cell types. The primary mechanisms include active transport along cytoskeletal elements, diffusion with subsequent anchoring, and localized protection from degradation [22]. Active transport represents the best-characterized mechanism, involving the movement of ribonucleoprotein (RNP) complexes along microtubule or actin networks via molecular motors. Microtubule-based transport typically utilizes kinesin superfamily proteins for anterograde movement toward microtubule plus-ends and dynein for retrograde movement toward minus-ends [22]. In both neuronal and epithelial systems, this transport occurs in a translationally repressed state, with mRNAs becoming translationally active only upon reaching their destination [69].

The specificity of RNA localization is largely determined by cis-regulatory elements, commonly called "zipcodes," which are typically found in the 3' untranslated regions (UTRs) of mRNAs, though 5' UTR elements also play significant roles [54] [70]. These zipcodes are recognized by trans-acting RBPs that link the mRNA to motor complexes and regulate translational repression during transport. Recent high-throughput studies have identified hundreds of localized mRNAs in both neuronal and epithelial cells, suggesting that this phenomenon is far more widespread than previously appreciated [71] [72] [70].

Table 1: Core Mechanisms of RNA Localization Across Cell Types

Mechanism	Key Molecular Players	Neuronal Role	Epithelial Role
Active Microtubule Transport	Kinesin-1, Dynein, RNP complexes	Axonal/dendritic transport of β-actin, CaMKIIα mRNAs [22]	Basal localization of RP mRNAs in intestinal enterocytes [54]
mRNA Anchoring	Actin cytoskeleton, EF1α, APC complex	Maintenance of β-actin mRNA at synapses [22]	Anchoring of NET1 mRNA at basal protrusions [73]
Localized Degradation/Protection	NMD pathway, Smaug protein	Regulation of RNA abundance in dendrites and growth cones [22]	Posterior protection of Hsp83 mRNA in Drosophila embryos [22]
Cis-Regulatory Elements	Zipcode sequences in 3' and 5' UTRs	let-7 binding site, (AU)n motifs in neurites [70]	Pyrimidine-rich motifs in 5' UTRs for basal localization [54]

Conserved Molecular Machinery in Neuronal and Epithelial Systems

RNA-Binding Proteins as Universal Regulators

RNA-binding proteins serve as the central interpreters of the RNA localization code across different cell types. LARP1 exemplifies this conservation, functioning as a key regulator in both neuronal and epithelial systems. In epithelial cells, LARP1 recognizes pyrimidine-rich motifs in the 5' UTRs of ribosomal protein (RP) mRNAs to direct their basal localization [54]. The identical mechanism operates in neuronal cells, where the same motifs direct RNA localization to neurites, with LARP1 perturbation abolishing localization in both systems [54]. This conservation extends to other RBPs, including ZBP1, which regulates β-actin mRNA localization in both neuronal growth cones and fibroblast protrusions [22] [70].

The dynein/Bicaudal-D (BicD)/Egalitarian (Egl) complex represents another universally employed machinery, directing apical RNA localization in epithelial follicular cells and participating in RNA transport in neurons [71]. Similarly, the kinesin-1 motor complex, along with its regulatory component atypical Tropomyosin-1 (aTm1), mediates basal RNA localization in epithelial cells and posterior transport in Drosophila oocytes, demonstrating functional conservation across evolutionarily divergent systems [71].

Cis-Regulatory Elements and Motif Conservation

Zipcode identification reveals remarkable conservation of specific RNA motifs that direct localization across cell types. Systematic analysis using the Neuronal Zipcode Identification Protocol (N-zip) has identified the let-7 microRNA binding site (CUACCUC) and (AU)n motifs as de novo zipcodes in primary cortical neurons [70]. These motifs are necessary and sufficient for neurite localization when introduced into heterologous sequences. The (AU)n motif, in particular, requires a minimum of six repeats for efficient localization function [70].

Parallel studies in epithelial systems have identified pyrimidine-rich tracts in 5' UTRs as critical determinants for basal localization of RP mRNAs [54]. The conservation of these mechanisms is evidenced by the finding that the same pyrimidine-rich motifs sufficient to drive RNA localization to intestinal epithelial basal poles also direct localization to neuronal neurites, with both processes requiring LARP1 and kinesin-1 function [54].

Table 2: Conserved Cis-Regulatory Elements and Their Trans-Acting Factors

Cis-Element	Sequence Features	Trans-Factors	Neuronal Localization	Epithelial Localization
let-7 binding site	CUACCUC	let-7 miRNA family	Neurite enrichment of Mcf2l, Cflar mRNAs [70]	Not explicitly stated
(AU)n motif	(AU) repeats, n≥6	Unknown RBPs	Neurite localization of Rassf3, Cox5b mRNAs [70]	Not explicitly stated
Pyrimidine-rich 5' UTR	C/U-rich motifs in 5' UTR	LARP1	Neurite localization of RP mRNAs [54]	Basal localization in intestinal enterocytes [54]
CPE	U-rich cytoplasmic polyadenylation element	CPEB	Dendritic localization of Map2, Bdnf mRNAs [70]	Not explicitly stated

Experimental Evidence for Mechanistic Conservation

Transcriptome-Wide Studies Reveal Shared Localization Patterns

High-throughput spatial transcriptomic analyses provide compelling evidence for mechanistic conservation between neuronal and epithelial systems. Comparison of subcellular RNA sequencing data from neuronal and epithelial cells reveals that the basal compartment of epithelial cells and the projections of neuronal cells are enriched for highly similar sets of RNAs, despite their morphologically distinct destinations [54]. This observation suggests that broadly similar mechanisms transport RNAs to these functionally analogous locations.

In intestinal epithelial cells, transcriptome-wide mapping using APEX-seq and MERFISH has identified distinct apically and basally enriched transcript populations, with apical transcripts enriched for genes involved in nutrient sensing, digestion, and pathogen defense, while basal transcripts include ribosomal proteins and metabolic regulators [72]. Remarkably, these compartment-specific enrichment patterns mirror the functional specialization observed in neuronal systems, where synaptic transcripts localize to distal neurites while housekeeping genes remain somatically enriched.

Functional Validation of Conserved Mechanisms

Direct experimental validation demonstrates that RNA localization mechanisms are functionally interchangeable between cell types. When RNA elements identified as epithelial basal localization signals are introduced into neuronal cells, they direct localization to neurites, and vice versa [54]. This functional transferability extends to the required molecular machinery, as perturbation of kinesin-1 disrupts basal RNA localization in epithelial cells and similarly impairs RNA transport to neuronal projections [54] [71].

The functional consequences of disrupted RNA localization further highlight this conservation. In epithelial tissue, preventing Net1 mRNA localization to the dermal-epidermal junction alters junctional morphology and keratinocyte-matrix connections through dysregulated RhoA signaling [73]. Similarly, in neurons, disrupted mRNA localization impairs synaptic function, axon guidance, and structural plasticity, often through analogous signaling pathways including Rho GTPases [22] [70].

Advanced Methodologies for Investigating RNA Localization

Spatial Transcriptomics and Proximity Labeling Techniques

Cutting-edge methodologies have revolutionized our ability to map RNA localization transcriptome-wide. Proximity labeling techniques, particularly APEX-seq and Halo-seq, enable high-resolution mapping of subcellular RNA distributions by using engineered peroxidases to biotinylate RNAs in specific compartments [54] [72]. APEX-seq employs the APEX2 ascorbate peroxidase fused to compartment-specific proteins (e.g., DPP4 for apical membrane targeting) to catalyze biotin-phenol oxidation in presence of Hâ‚‚Oâ‚‚, selectively labeling proximal RNAs within a 20nm radius [72]. The biotinylated RNAs are then isolated using streptavidin pulldown and identified by next-generation sequencing.

Halo-seq utilizes a similar principle, employing HaloTag fusion proteins targeted to specific subcellular locations [54]. Upon addition of a dibromofluorescein (DBF)-conjugated Halo ligand and exposure to green light, singlet oxygen generation leads to oxidation and subsequent alkynylation of proximal RNA bases. These labeled RNAs are then biotinylated via click chemistry for streptavidin-based purification and sequencing. This technique has been successfully adapted for both epithelial monolayers and neuronal systems, enabling direct comparison of localization patterns [54].

High-Throughput Zipcode Identification

The Neuronal Zipcode Identification Protocol (N-zip) represents a powerful approach for systematically identifying cis-regulatory elements that mediate RNA localization [70]. This method combines massively parallel reporter assays with physical separation of neuronal compartments (soma versus neurites) using microporous membranes. Researchers create lentiviral libraries of GFP reporters containing tiled fragments from 3' UTRs of neurite-enriched transcripts, infect primary cortical neurons cultured on membranes, and separately sequence RNAs from somata and neurites after compartmental separation. Statistical comparison of enrichment ratios identifies zipcode-containing fragments, which can be further refined through comprehensive mutagenesis studies [70].

Diagram 1: N-zip workflow for high-throughput zipcode identification

Single-Molecule Fluorescence In Situ Hybridization (smFISH)

Single-molecule FISH remains the gold standard for validating RNA localization with single-molecule resolution [54] [72]. This technique uses multiple fluorescently labeled oligonucleotide probes hybridizing to individual mRNA molecules, allowing precise quantification and subcellular localization. Advanced multiplexed smFISH approaches now enable simultaneous detection of dozens to hundreds of different transcripts, providing spatial transcriptomic data with subcellular resolution [72]. In both epithelial and neuronal systems, smFISH has been instrumental in characterizing granular RNA distributions and validating localization patterns identified through sequencing-based methods.

The Scientist's Toolkit: Essential Research Reagents

Table 3: Key Research Reagents for Investigating RNA Localization

Reagent/Category	Specific Examples	Function/Application	Experimental Context
Proximity Labeling Enzymes	APEX2, HaloTag	Covalent labeling of proximal RNAs for purification and identification	APEX-seq in intestinal organoids [72]; Halo-seq in epithelial monolayers [54]
Compartment-Specific Markers	DPP4 (apical), MITO-APEX2 (mitochondrial)	Target proximity labeling enzymes to specific subcellular compartments	Apical RNA profiling in epithelial cells [72]
Spatial Separation Systems	Microporous membrane cultures	Physical separation of neuronal soma and neurites for compartment-specific RNA analysis	N-zip protocol in primary cortical neurons [70]
Motor Protein Inhibitors	Kinesin-1 inhibitors, Dynein inhibitors	Disrupt active transport mechanisms to test dependency	Kinesin-1 disruption in follicular epithelium [71]
RBP Perturbation Tools	LARP1 knockdown, Dominant-negative constructs	Test functional requirements of specific RNA-binding proteins	LARP1 perturbation in epithelial and neuronal cells [54]
Zipcode Reporter Libraries	GFP-3' UTR fibraries, Massively parallel reporters	High-throughput identification of cis-regulatory elements	N-zip tiled library screening [70]
Spatial Transcriptomics Platforms	MERFISH, smFISH	Subcellular localization mapping with single-molecule resolution	RNA granular pattern identification in intestinal organoids [72]

Signaling Pathways and Molecular Interactions

The functional outcomes of RNA localization are frequently mediated through compartmentalized activation of specific signaling pathways. A prime example is the Net1 mRNA/RhoA pathway, which operates similarly in both mesenchymal protrusions and epithelial basal domains [73]. Net1 mRNA localization to specific subcellular compartments determines where NET1 protein is synthesized, which in turn influences the nucleotide exchange factor's access to its substrate, RhoA. At protrusions or basal membrane domains, locally synthesized NET1 associates with membrane-bound scaffolds where it activates RhoA to influence cytoskeletal dynamics [73]. In contrast, perinuclear Net1 mRNA translation produces NET1 that binds importins and undergoes nuclear sequestration, demonstrating how mRNA location directly influences protein interactors and functional outcomes.

Diagram 2: NET1 mRNA localization determines functional protein outcomes

This paradigm extends to other localized mRNAs, including those encoding ribosomal proteins whose localized translation may influence the compartment-specific capacity for protein synthesis [54]. The conservation of these pathways across cell types highlights the fundamental nature of RNA localization as a mechanism for spatial control of signaling and cellular organization.

The mechanistic conservation of RNA localization codes between neuronal and epithelial cells reveals fundamental principles of cellular organization that transcend traditional cell type classifications. The shared dependence on specific RBPs, motor complexes, and cis-regulatory elements demonstrates that evolution has co-opted a limited toolkit to achieve localized protein synthesis across diverse cellular contexts. This conservation provides researchers with powerful predictive capabilities: localization mechanisms identified in one cell type can inform hypotheses and experimental approaches in other systems.

Future research directions include systematic identification of additional zipcode elements across cell types, elucidation of how RNA localization interfaces with translational control mechanisms, and exploration of how disruption of these conserved mechanisms contributes to disease pathogenesis. The development of increasingly sophisticated spatial transcriptomics technologies will undoubtedly reveal further complexity in the RNA localization code and its conservation across the full spectrum of polarized cells. For drug development professionals, these conserved mechanisms offer potential therapeutic targets, as disrupting pathological RNA localization may provide cell-type specific interventions while leveraging fundamental biological pathways shared across tissues.

This technical guide details the functional validation of two membrane-associated extracellular RNAs (maxRNAs), FNDC3B and Cathepsin S (CTSS), in mediating monocyte adhesion to vascular endothelial cells. The adhesion of monocytes to the endothelium is a pivotal event in the initiation and progression of inflammatory diseases and cancer metastasis. Emerging research on cell surface RNA localization has revealed an expanded role for RNA in cell-environment interactions. Within this paradigm, we present comprehensive case studies on FNDC3B and CTSS, summarizing quantitative data, experimental protocols, and signaling pathways to provide a validated methodological framework for researchers and drug development professionals exploring the therapeutic potential of maxRNAs.

The conventional understanding of the cell surface proteome is being redefined by the discovery of stable, nuclear-encoded RNAs on the extracellular face of the plasma membrane, termed membrane-associated extracellular RNAs (maxRNAs). Unlike vesicle-encapsulated or cell-free RNAs, maxRNAs are stably attached to cell membranes and exposed to the extracellular space [74]. This localization suggests direct involvement in extracellular interactions, including cell-cell communication and adhesion.

The functional characterization of maxRNAs requires sophisticated techniques to distinguish them from intracellular RNAs and demonstrate their biological significance. This guide focuses on two exemplars—FNDC3B and CTSS—whose functional validation in monocyte-endothelial adhesion provides a template for maxRNA research.

Core Technologies for maxRNA Discovery and Validation

Surface-seq for maxRNA Profiling

Surface-seq is a nanotechnology-based method for selectively sequencing maxRNAs [74].

• Principle: Plasma membranes are extracted from cells and tightly assembled around polymeric cores to form membrane-coated nanoparticles (MCNPs), preserving the inside-outside orientation of the membrane.
• Workflow:
  • MCNP Assembly: Cell membrane purification and coating onto polymeric cores, ensuring rigorous removal of intracellular contents.
  • RNA Capture: Two technical variations are employed:
    • Variation A: Extracts all membrane-associated RNAs after MCNP assembly.
    • Variation B: Selectively ligates a 3' RNA adaptor to outside-facing RNAs on intact MCNPs, enriching for maxRNAs in the sequencing library.
  • Library Construction and Sequencing: Standard RNA-seq library preparation from the captured RNA.
• Outcome: Identifies candidate maxRNAs, such as FNDC3B and CTSS, that are consistently present on the outer cell membrane.

Surface-FISH for maxRNA Visualization

Surface-FISH (Fluorescence In Situ Hybridization) validates the extracellular localization of candidate maxRNAs [74].

• Principle: Adapted from single-molecule RNA-FISH but omits the cell membrane permeabilization step, ensuring only surface-exposed RNAs are probed.
• Protocol:
  • Probe Design: A set of five quantum-dot-labeled oligonucleotide probes (40 nt each) are designed against the target transcript.
  • Hybridization: Live, intact cells are incubated with the probe set.
  • Control Experiments: Probes with central mutated bases (e.g., mut-Malat1) serve as negative controls to confirm specificity.
  • Validation of Membrane Integrity: Combined with transmission-through-dye (TTD) microscopic analysis to confirm signals originate from cells with intact membranes.
• Outcome: Provides visual confirmation of specific maxRNAs on the surface of live cells.

Case Study 1: FNDC3B in Monocyte Adhesion

Background and Biological Rationale

FNDC3B (fibronectin type III domain containing 3B) is an endoplasmic reticulum transmembrane protein with nine fibronectin type III (FNIII) domains, known to regulate cell adhesion, spreading, and migration [75] [76]. Its role as an oncogene in hepatocellular carcinoma, glioma, and other cancers is well-established, where it promotes migration, invasion, and metastasis [75] [77] [78]. High FNDC3B expression correlates with poor patient survival and shorter recurrence times [75]. These pro-adhesive properties made it a compelling candidate for functional validation as a maxRNA in monocyte adhesion.

Functional Validation Experiments

The functional role of surface-exposed FNDC3B RNA was tested using an antisense oligonucleotide (ASO) approach on human peripheral blood mononuclear cells (PBMCs) [74].

• Experimental System: Primary human PBMCs and vascular endothelial cell cultures.
• Functional Assay: Monocyte adhesion to endothelial cells.
• Intervention: Extracellular application of antisense oligos targeting the single-stranded FNDC3B transcript exposed on the PBMC surface.
• Key Finding: Antisense oligos against FNDC3B significantly inhibited monocyte adhesion to vascular endothelial cells [74].

Table 1: Summary of FNDC3B Functional Data

Assay Type	Experimental Model	Intervention	Key Result	Biological Implication
Functional Validation	Human PBMCs & Endothelial Cells	Extracellular FNDC3B ASO	Inhibition of monocyte adhesion	FNDC3B maxRNA promotes cell adhesion
Supporting Evidence
Cell Migration [75]	HCC Cell Lines	FNDC3B Overexpression	Enhanced cell migration	Promotes motility
		FNDC3B Knockdown (shRNA)	Inhibition of migration & invasion
In Vivo Metastasis [75]	Mouse Xenograft Model	FNDC3B Knockdown	>60% reduction in tumor nodules	Promotes metastasis
Clinical Correlation [75]	HCC Patient Tissues	Expression Analysis	Overexpressed in metastatic HCC vs primary	Correlates with poor survival

Molecular Mechanism of FNDC3B

The molecular mechanism by which FNDC3B facilitates cell migration and adhesion has been partially elucidated.

• Critical Domains: The first four FNIII domains (1-4) are essential for FNDC3B's migration-inducing activity. Deletion of these domains ablates its function [75].
• Protein Interaction: FNDC3B cooperates with Annexin A2 (ANXA2). Co-immunoprecipitation and LC-MS/MS analyses showed that FNDC3B interacts with phosphorylated ANXA2, and this interaction is dependent on the FNIII 1-4 domains [75].
• Downstream Signaling: The FNDC3B-ANXA2 axis promotes cell migration by mediating Rho-mediated actin rearrangement, leading to the formation of well-defined stress fibers. This effect is reversed by Rho inhibitor treatment [75].

Diagram 1: FNDC3B signaling pathway in adhesion.

Case Study 2: CTSS in Monocyte-Endothelial Interaction

Background and Biological Rationale

Cathepsin S (CTSS) is a lysosomal cysteine protease with elastolytic activity, capable of functioning in extracellular matrix degradation. It is involved in antigen presentation, inflammation, and a variety of pathological processes, including cancer, cardiovascular disease, and arthritis [79] [80]. CTSS expression is significantly higher in diabetic patients and serves as a biomarker for diabetes and atherosclerosis [79]. Its role in vascular remodeling and inflammatory processes made it a strong candidate for regulating monocyte-endothelial interactions.

Functional Validation Experiments

The role of CTSS was validated in the same maxRNA functional screen as FNDC3B [74], and its mechanisms have been further detailed in hyperglycemia models.

• Experimental System:
  • maxRNA Screen: Primary human PBMCs [74].
  • Mechanistic Studies: Human Umbilical Vein Endothelial Cells (HUVECs) under high glucose (HG; 30 mM) to induce hyperglycemia [79].
• Interventions:
  • maxRNA Screen: Extracellular application of CTSS antisense oligos on PBMCs [74].
  • In vitro Knockdown: CTSS-specific siRNA transfection in HUVECs [79].
• Key Findings:
  • CTSS antisense oligos inhibited monocyte adhesion to endothelial cells [74].
  • In HUVECs, high glucose upregulated CTSS and pro-inflammatory cytokines (TNF-α, IL-1β, IL-6) [79].
  • CTSS knockdown under high glucose:
    • Suppressed expression of inflammatory cytokines and vascular adhesion markers (VCAM-1, ICAM-1).
    • Inhibited angiogenic activity in tube formation assays.
    • Downregulated the NF-κB signaling pathway [79].

Table 2: Summary of CTSS Functional Data

Assay Type	Experimental Model	Intervention	Key Result	Biological Implication
Functional Validation	Human PBMCs & Endothelial Cells	Extracellular CTSS ASO	Inhibition of monocyte adhesion	CTSS maxRNA promotes adhesion
Supporting Evidence
In vitro Knockdown [79]	HUVECs (High Glucose)	CTSS siRNA	Downregulated inflammatory cytokines (TNF-α, IL-1β, IL-6)	Mitigates inflammation
			Downregulated adhesion markers (VCAM-1, ICAM-1)	Reduces pro-adhesive state
			Inhibited NF-κB signaling & angiogenesis	Underlying mechanism
Clinical Correlation [80]	Human Studies	Expression Analysis	Elevated in diabetes, atherosclerosis	Biomarker for disease

Molecular Mechanism of CTSS

CTSS promotes a pro-inflammatory and pro-adhesive environment in endothelial cells through a defined signaling cascade.

• Induction: High glucose conditions upregulate CTSS expression in endothelial cells.
• Inflammatory Signaling: CTSS activity promotes the activation of the NF-κB pathway, a master regulator of inflammation.
• Downstream Effects: NF-κB activation leads to:
  • Increased expression of pro-inflammatory cytokines (TNF-α, IL-1β, IL-6).
  • Upregulation of vascular adhesion markers (VCAM-1, ICAM-1), which facilitate monocyte binding.
  • Enhanced angiogenic activity [79].

Diagram 2: CTSS signaling in endothelial adhesion.

The Scientist's Toolkit: Research Reagent Solutions

Table 3: Essential Reagents for maxRNA Functional Studies

Reagent / Tool	Specific Example	Function in Experiment
Antisense Oligonucleotides (ASOs)	FNDC3B ASO, CTSS ASO [74]	Hybridize to and block the function of specific, single-stranded maxRNAs on the cell surface without requiring cellular internalization.
Membrane-Coated Nanoparticles (MCNPs)	Polymeric core MCNPs [74]	Isolate and preserve the native orientation of the plasma membrane for maxRNA extraction and sequencing (Surface-seq).
Surface-FISH Probe Sets	Quantum-dot-labeled 40mer probes [74]	Visualize the spatial localization of specific maxRNAs on the surface of live, non-permeabilized cells.
siRNA/shRNA	CTSS siRNA [79], FNDC3B shRNA [75]	Knockdown total cellular mRNA and protein levels in vitro to investigate overall gene function and mechanisms.
Validated Antibodies	Anti-FNDC3B [81], Anti-CTSS [79]	Detect protein expression and cellular localization via Western Blot, Immunofluorescence, and Immunohistochemistry.
Specialized Cell Culture Models	HUVECs under High Glucose [79], PBMCs from donors [74]	Model disease-specific conditions (e.g., hyperglycemia) or use primary cells for physiologically relevant functional assays.
Functional Assay Kits	Monocyte-Endothelial Adhesion Assay, Tube Formation Assay [79], Cell Migration/Invasion Assay [75]	Quantify the functional outcomes of maxRNA manipulation (adhesion, angiogenesis, migration).

Integrated Experimental Workflow

The following diagram synthesizes the key methodological steps for the discovery and functional validation of maxRNAs like FNDC3B and CTSS, from initial identification to mechanistic insight.

Diagram 3: maxRNA discovery and validation workflow.

The functional validation of FNDC3B and CTSS establishes a compelling precedent for maxRNAs as functional components at the cell surface, directly regulating critical processes like monocyte-endothelial adhesion. The methodologies outlined—from Surface-seq and Surface-FISH to extracellular ASO-mediated functional blockade—provide a robust template for the discovery and validation of other maxRNAs. Targeting these surface-exposed RNAs with antisense oligonucleotides presents a novel therapeutic strategy for intervening in inflammatory and metastatic diseases. Future work will focus on elucidating the precise mechanisms of maxRNA attachment to the membrane and expanding the catalog of functional maxRNAs across different cell types and disease states.

The conventional understanding of RNA biology has historically confined its roles to the intracellular spaces of the nucleus and cytoplasm. However, a paradigm-shifting discovery has revealed the presence of specific RNA molecules, notably glycoRNAs, on the outer surface of mammalian cells [18]. These glycoRNAs are defined as small non-coding RNAs that are covalently modified by complex N-glycans, and their presence on the cell surface positions them as novel and promising targets for therapeutic intervention and biomarker development [18] [8]. This emerging field sits at the intersection of RNA biology, immunology, and glycobiology, suggesting that the cell surface is a new platform for RNA-mediated functions [8].

The localization of RNA on the cell surface suggests a direct role in mediating communication between the cell and its external environment. A growing body of evidence indicates that cell surface glycoRNAs are integral to immune homeostasis and the orchestration of immune cell behavior [18]. Preliminary studies propose their involvement in critical processes such as immune cell adhesion, infiltration, and activation, which are fundamental to immune surveillance and the response to pathogens and disease [18]. Furthermore, the discovery of RNA-binding proteins (RBPs) at the cell surface provides a mechanistic framework for understanding how RNAs might be stabilized and function in this unique locale, and also offers new insights into longstanding clinical observations, such as the prevalence of autoantibodies against RBPs in autoimmune diseases like systemic lupus erythematosus (SLE) [8]. This whitepaper provides an in-depth technical guide to the current state of knowledge, methodologies, and future directions for harnessing cell surface RNAs in drug discovery and diagnostics.

The Biological Framework of Cell Surface RNAs

GlycoRNAs and Their Biosynthesis

GlycoRNAs represent one of the most intriguing discoveries in recent cell surface biology. Their biosynthesis is an intracellular process that culminates in their surface localization, though the precise mechanisms remain an active area of investigation [18]. It is proposed that these RNAs undergo a post-transcriptional modification pathway analogous to protein N-glycosylation, where complex N-glycans are covalently attached to RNA molecules [18]. This surprising finding blurs the traditional lines between nucleic acid and glycoconjugate biology. The synthesis and transport of these molecules to the cell surface are critical areas for further research, with outstanding questions regarding their origin, the specific enzymes involved in their glycosylation, and the transport mechanisms that deliver them to the plasma membrane [18].

Functional Roles in Immune Regulation and Disease

The functional implications of cell surface RNAs, particularly in immune regulation, are profound. They are hypothesized to play pivotal roles in cell signaling and immune processes [18]. One leading hypothesis is that surface glycoRNAs interact with immune cell receptors, thereby modulating immune responses [18]. This interaction could have significant implications for both autoimmune diseases and cancer [18].

In autoimmune contexts, the presence of glycoRNAs and RBPs on the cell surface may explain the generation of autoantibodies. For example, the La protein (an RBP) has been observed to shuttle to the cell surface after UV irradiation, making it accessible to autoantibodies [8]. Similarly, surface-expressed nucleolin can serve as a receptor for various ligands, exposing it to the immune system [8]. This provides a new model for understanding how canonically nuclear antigens become targets in autoimmune conditions. In cancer, surface RNAs may contribute to immune evasion or metastasis, potentially through interactions that alter immune cell adhesion and activation [18] [8]. The role of the SID-1 protein, found in humans and other animals, in regulating the intergenerational transport of double-stranded RNA (dsRNA) also highlights a complex layer of gene regulation that could be leveraged for therapies that control the inheritance of certain disease states [82].

Table 1: Key Functional Implications of Cell Surface RNAs

Functional Area	Proposed Role of Cell Surface RNAs	Potential Disease Link
Immune Surveillance	Mediate immune cell adhesion, infiltration, and activation [18].	Response to pathogens, cancer immunology.
Autoimmunity	Act as autoantigens; form complexes with csRBPs that are recognized by autoantibodies [8].	Systemic Lupus Erythematosus (SLE), Scleroderma.
Cancer Biology	Influence immune evasion; potential role in metastasis [18].	Cancer progression, response to immunotherapy.
Intercellular Signaling	Facilitate RNA transfer between cells via proteins like SID-1 [82].	Heritable epigenetic changes, drug delivery.

Cell Surface RNAs as Therapeutic Targets

Targeting Strategies and Mechanisms of Action

The unique localization and structure of cell surface RNAs make them amenable to various targeting strategies. Several mechanistic approaches can be employed to therapeutically modulate their function:

• Splicing Modulation: This is one of the most clinically validated strategies for RNA-targeting therapeutics, as exemplified by the FDA-approved drug risdiplam [52]. While not yet applied to surface RNAs directly, it demonstrates the feasibility of targeting RNA with small molecules.
• RNA Degradation: Targeted RNA degraders, such as those that recruit endogenous nucleases, represent a promising frontier for directly reducing the abundance of specific cell surface RNAs [52] [83].
• Modulation of RNA-Protein Interactions (RPIs): Small molecules can be designed to disrupt or stabilize the interactions between cell surface RNAs and their binding proteins (csRBPs), thereby altering downstream signaling or immune recognition [52].
• Antibody-Based Therapies: The surface localization of glycoRNA-csRBP complexes makes them accessible to therapeutic antibodies. This is supported by the historical presence of autoantibodies against these complexes in autoimmune patients, proving their immunogenicity and "druggability" [8].

Technological Enablers in Drug Discovery

The discovery of drugs targeting cell surface RNAs is being accelerated by several cutting-edge technologies:

• Single-Cell RNA Sequencing (scRNA-seq): scRNA-seq is transforming drug discovery by enabling improved disease understanding through cell subtyping and highly multiplexed functional genomics screens [84]. It can identify which cell subpopulations express specific surface RNAs, credential and prioritize targets, and provide insights into drug mechanisms of action [84].
• Artificial Intelligence and Machine Learning: AI/ML is playing a pivotal role in analyzing complex data and accelerating the discovery of RNA-targeted compounds [52] [49]. Deep learning and molecular docking are enhancing RNA structure prediction and the efficiency of virtual ligand screening [52].
• Advanced Screening Methodologies: Innovative approaches such as DNA-encoded libraries (DELs), fragment-based drug discovery, and small-molecule microarrays are effectively expanding the chemical space for identifying bioactive ligands that bind to RNA structures [52].

Table 2: Key Technologies for Discovering RNA-Targeted Therapeutics

Technology	Application in Drug Discovery	Relevance to Cell Surface RNA
Single-Cell RNA Sequencing (scRNA-seq)	Target identification/validation, cell subtyping, understanding MoA [84].	Identifies cell populations expressing specific surface RNAs.
DNA-Encoded Libraries (DELs)	High-throughput identification of RNA-binding small molecules [52].	Screening for ligands against surface RNA motifs.
Fragment-Based Drug Discovery	Exploring chemical space for RNA binders [52].	Discovering chemical starting points for targeting surface RNAs.
Artificial Intelligence/Machine Learning	RNA structure prediction, ligand screening/design [52] [49].	Predicting surface RNA conformations and designing specific binders.

Diagram 1: Therapeutic targeting of cell surface RNA.

Cell Surface RNAs as Biomarkers

Detection and Profiling Technologies

The detection of extracellular RNAs, including those on the cell surface, requires specialized and sensitive methodologies. Key technologies enabling their use as biomarkers include:

• Surface-Enhanced Raman Spectroscopy (SERS): SERS is a powerful biosensing application for biomarker detection due to its high sensitivity and ability to perform multiplexed analysis. It has been successfully used with inverse Molecular Sentinels (iMS) nanosensors to detect microRNA (miRNA) biomarkers for biomedical diagnosis [85] [86]. When combined with machine learning algorithms like convolutional neural networks (CNN), SERS enables accurate spectral unmixing of multiplexed signals, which is crucial for analyzing complex clinical samples [85].
• Liquid Biopsy and Multi-Omics Platforms: Minimally invasive profiling of cell-free RNA (cfRNA) from blood samples is a rapidly advancing field. Advanced computational platforms can deconvolute cfRNA data to provide insights into the tumor microenvironment (TME) and identify predictive gene expression signatures, potentially capturing signals derived from cell surface RNAs [87].
• Immune System Profiling: High-resolution flow cytometry coupled with whole transcriptome sequencing can evaluate functional cell states and cellular composition from a blood sample. This can be used to predict immunotherapy response and immune-related adverse events, which may be influenced by cell surface RNA-mediated interactions [87].

Application in Disease Diagnosis and Monitoring

The application of cell surface RNA biomarkers spans several critical areas in clinical management:

• Cancer Diagnostics and Subtyping: Cancer is a complex disease with numerous subtypes that can be categorized based on distinct biomarkers, including miRNA [86]. SERS-based detection of these biomarkers from both invasive (e.g., tissue biopsies) and non-invasive (e.g., blood, urine) samples holds great promise for personalized disease management [86].
• Predictive Biomarkers for Therapy Response: Multi-gene expression signatures derived from RNA sequencing data can identify patients most likely to respond to specific therapies, such as immunotherapy or tyrosine kinase inhibitors [87].
• Autoimmune Disease Profiling: The presence of autoantibodies against cell surface RNP complexes provides a direct, serological biomarker for autoimmune conditions, offering a potential explanation for their origin and a tool for diagnosis [8].

Table 3: Biomarker Detection Platforms for Cell Surface RNA

Platform/Technology	Key Feature	Application Example
SERS with iMS Nanosensors	Multiplexed analysis, high sensitivity for miRNA [85] [86].	Detection of cancer miRNA biomarkers in clinical biopsies [85].
Liquid Biopsy (cfRNA)	Minimally invasive, provides TME insights [87].	Monitoring treatment response, residual disease [87].
Multi-Omics AI Platforms	Deconvolutes bulk RNA-seq to single-cell resolution [87].	Identifying TME subtypes predictive of therapy response [87].
High-Resolution Flow Cytometry	Deep immunophenotyping from blood [87].	Predicting immune-related adverse events from immunotherapy [87]. ```

Diagram 2: Biomarker discovery workflow.

Experimental Protocols for Key Analyses

Protocol for SERS-Based Detection of miRNA Biomarkers

This protocol outlines the procedure for detecting microRNA biomarkers using Surface-Enhanced Raman Spectroscopy (SERS) with inverse Molecular Sentinel (iMS) nanosensors, as detailed in the research by [85].

• Nanosensor Fabrication: Design and synthesize iMS nanosensors. These typically consist of a plasmonic-active nanoparticle (e.g., gold nanorod or sphere) functionalized with a Raman reporter molecule and a single-stranded DNA probe complementary to the target miRNA.
• Sample Preparation and Hybridization:
  • Extract total RNA from clinical samples (e.g., endoscopic tissue biopsies or biofluids).
  • Incubate the RNA sample with the iMS nanosensors under conditions that permit the target miRNA to hybridize to the DNA probe. This hybridization event induces a conformational change in the nanosensor, altering its SERS signal.
• SERS Spectral Acquisition:
  • Use a Raman spectrometer to collect SERS spectra from the sample-nanosensor mixture.
  • Employ a laser excitation source appropriate for the nanosensor's plasmon resonance. Collect multiple spectra to ensure statistical robustness.
• Data Pre-processing and Dimensionality Reduction:
  • Apply Non-Negative Matrix Factorization (NMF) to the raw SERS spectral data. This step reduces the data's dimensionality, decreasing computational demands for subsequent analysis while preserving critical information content [85].
• Spectral Unmixing and Analysis with Machine Learning:
  • Input the NMF-transformed data into a machine learning model for spectral unmixing. A Convolutional Neural Network (CNN) has been shown to achieve high accuracy in this task, distinguishing the contributions of different miRNAs in a multiplexed assay [85].
  • Train the model on known multiplexed SERS data and validate its performance using metrics like Root Mean Square Error (RMSE).
• Model Interpretation: Use interpretability methods such as gradient class activation maps and partial dependency plots to understand the model's predictions and validate the biological relevance of the features it uses [85].

Protocol for Investigating Cell Surface RNA-Protein Complexes

This protocol describes methodologies for identifying and characterizing RNA-binding proteins (RBPs) on the cell surface and their associated RNAs, as inferred from [8].

• Cell Surface Proteomics:
  • Isolate pure plasma membrane fractions from cells of interest using density gradient centrifugation or commercial membrane protein isolation kits.
  • Digest the membrane proteins with trypsin and analyze the peptides by liquid chromatography-tandem mass spectrometry (LC-MS/MS).
  • Cross-reference the identified proteins with established RBP databases to generate a list of high-confidence cell surface RBPs (csRBPs) [8].
• Crosslinking Immunoprecipitation (CLIP):
  • To capture direct RNA-protein interactions on the cell surface, subject live cells to mild UV crosslinking. This covalently links RNAs to their binding proteins that are in direct contact.
  • Lyse the cells and immunoprecipitate the target csRBP using a specific antibody.
  • Digest unbound RNA and protein, then isolate the crosslinked RNA fragments. Prepare these fragments for high-throughput sequencing (CLIP-seq) to identify the exact RNA sequences bound by the csRBP [8].
• Functional Validation:
  • Knock down or knock out the candidate csRBP using CRISPR/Cas9 or RNAi.
  • Assess functional phenotypes such as changes in immune cell adhesion, response to external ligands, or alterations in intercellular communication.
  • Analyze changes in the surface localization of partner RNAs via flow cytometry or imaging after staining with fluorescently labeled oligonucleotide probes.

The Scientist's Toolkit: Essential Research Reagents and Materials

Table 4: Key Reagent Solutions for Cell Surface RNA Research

Reagent/Material	Function/Application	Specific Examples / Notes
Gold Nanoparticles	Core for SERS nanosensors; plasmonic enhancement [85] [86].	Gold nanorods or spheres functionalized with DNA probes.
iMS (inverse Molecular Sentinel) Nanosensors	Specific detection of target miRNA in biofluids and tissues [85].	DNA probe designed for target miRNA; contains Raman reporter.
SID-1 Recombinant Protein / Antibodies	Study dsRNA transport mechanisms across cells and generations [82].	Key for understanding natural RNA uptake, relevant for drug delivery.
Cell Surface Protein Isolation Kits	Enrichment of plasma membrane proteins for proteomic studies [8].	Critical for identifying csRBPs without contamination from intracellular proteins.
CLIP-Seq Kits	Genome-wide mapping of RNA-protein interactions [8].	Includes reagents for UV crosslinking, immunoprecipitation, and RNA-seq library prep.
Modified Nucleosides	Improve stability and reduce immunogenicity of therapeutic RNA [49].	e.g., pseudouridine for mRNA vaccine development.
Lipid Nanoparticles (LNPs)	Delivery vehicle for RNA therapeutics; protects RNA and facilitates cellular uptake [49].	Used in COVID-19 mRNA vaccines and other RNA-based therapies.
GalNAc Conjugation Reagents	Targeted delivery of RNA therapeutics to hepatocytes [49].	Used for siRNA therapeutics (e.g., Givosiran, Inclisiran).

The discovery of RNA molecules, particularly glycoRNAs, on the cell surface has unveiled a new frontier in biology with immense potential for therapeutic and diagnostic applications. This field is poised to revolutionize our understanding of cell signaling, immune regulation, and the mechanisms underlying autoimmune diseases and cancer. Future progress will hinge on interdisciplinary efforts that combine advanced structural biology (e.g., cryo-EM for determining surface RNA structures), sophisticated chemical biology for designing targeted degraders and modulators, and cutting-edge computational tools like AI for predicting interactions and optimizing drug candidates [52]. The integration of single-cell multi-omics and highly sensitive detection platforms like SERS will further accelerate the translation of cell surface RNA research from a fundamental biological curiosity into a cornerstone of next-generation precision medicine, offering novel strategies to drug some of the most challenging diseases.

Conclusion

The study of cell surface RNA localization represents a fundamental expansion of our understanding of the functional cell surface, moving beyond a purely protein- and lipid-centric view. Key takeaways confirm that maxRNAs are not artifacts but functional components with roles in critical processes like immune cell adhesion. The development of sophisticated tools like Surface-seq and proximity labeling has been instrumental in this discovery. Future research must focus on elucidating the precise molecular mechanisms that tether specific RNAs to the membrane and comprehensively mapping the 'surface-ome' across diverse cell types and states. For biomedical research and drug development, this field opens a new frontier. The cell-type specificity and functional involvement of maxRNAs in disease-relevant pathways position them as promising targets for novel therapeutic strategies, including the use of antisense oligonucleotides, and as a source of highly specific biomarkers for diagnosis and monitoring.

References

• 1. Natural display of nuclear-encoded RNA on the cell surface ... [https://genomebiology.biomedcentral.com/articles/10.1186/s13059-020-02145-6]
• 2. Natural display of nuclear-encoded RNA on the cell ... [https://escholarship.org/uc/item/0jt6b3s1]
• 3. An ontology-based knowledge graph for representing ... [https://www.nature.com/articles/s41597-024-03673-7]
• 4. miRNATissueAtlas 2025: an update to the uniformly ... [https://pmc.ncbi.nlm.nih.gov/articles/PMC11701691/]
• 5. Collective homeostasis of condensation-prone proteins via ... [https://www.nature.com/articles/s41586-025-09568-w]
• 6. GlycoRNA, a novel RNA modification - PMC - PubMed Central [https://pmc.ncbi.nlm.nih.gov/articles/PMC12494505/]
• 7. Surface-seq reveals nuclear-encoded RNA on the cell ... [https://www.rna-seqblog.com/surface-seq-reveals-nuclear-encoded-rna-on-the-cell-surface/]
• 8. Cell surface RNA biology: new roles for RNA binding proteins [https://www.sciencedirect.com/science/article/abs/pii/S0968000425000544]
• 9. A preliminary profile of RNA bound on the cell surface [https://pubs.rsc.org/uk/content/articlehtml/2025/sc/d5sc05806f]
• 10. Comparison of transcriptional activity profiling by metabolic ... [https://pmc.ncbi.nlm.nih.gov/articles/PMC12342705/]
• 11. The emerging role of GlycoRNAs in immune regulation and ... [https://www.sciencedirect.com/science/article/pii/S0165247825000811]
• 12. Molecular mechanisms behind mRNA localization in axons [https://pmc.ncbi.nlm.nih.gov/articles/PMC7536069/]
• 13. Mechanisms of microRNA trafficking to mitochondria in the ... [https://www.sciencedirect.com/science/article/abs/pii/S2468867325000367]
• 14. The lncRNA Malat1 is trafficked to the cytoplasm as a ... [https://pmc.ncbi.nlm.nih.gov/articles/PMC11146593/]
• 15. MALAT1: a druggable long non-coding RNA for targeted anti ... [https://jhoonline.biomedcentral.com/articles/10.1186/s13045-018-0606-4]
• 16. Deciphering the RNA landscapes on mammalian cell ... [https://www.eurekalert.org/news-releases/1106077]
• 17. New tool sheds light on where RNA is found in cells [https://www.utsouthwestern.edu/newsroom/articles/year-2025/june-tool-sheds-light-on-rna.html]
• 18. Frontiers | Cell RNAs and immune response surface [https://www.frontiersin.org/research-topics/75800/cell-surface-rnas-and-immune-response]
• 19. biology: new Cell for surface binding proteins. | HSCRB RNA roles RNA [https://hscrb.harvard.edu/publication/cell-surface-rna-biology-new-roles-for-rna-binding-proteins-trends-biochem-sci-2025-may-505402-416/]
• 20. A preliminary profile of RNA bound on the cell surface [https://pubs.rsc.org/en/content/articlelanding/2025/sc/d5sc05806f]
• 21. RNA localization mechanisms transcend cell morphology [https://elifesciences.org/articles/80040]
• 22. Mechanisms and consequences of subcellular RNA ... [https://pmc.ncbi.nlm.nih.gov/articles/PMC7304542/]
• 23. Functional insights into immunoglobulin superfamily ... [https://www.frontiersin.org/journals/immunology/articles/10.3389/fimmu.2025.1552151/full]
• 24. Functional insights into immunoglobulin superfamily ... [https://pubmed.ncbi.nlm.nih.gov/40242768/]
• 25. Quantitative characterization of immune cells by measuring ... [https://pubmed.ncbi.nlm.nih.gov/39424625/]
• 26. Pathways of Intracellular Signal Transduction - The Cell - NCBI [https://www.ncbi.nlm.nih.gov/books/NBK9870/]
• 27. Signal transduction [https://en.wikipedia.org/wiki/Signal_transduction]
• 28. Natural display of nuclear-encoded RNA on the cell surface ... [https://pubmed.ncbi.nlm.nih.gov/32907628/]
• 29. CITE-seq (Cellular Indexing of Transcriptomes & Epitopes ... [https://www.biorender.com/template/cite-seq-cellular-indexing-of-transcriptomes-epitopes-by-sequencing-workflow]
• 30. Quantitative measures to assess the quality of cellular ... [https://www.frontiersin.org/journals/bioinformatics/articles/10.3389/fbinf.2025.1630161/full]
• 31. Imputing abundance of over 2500 surface proteins from ... [https://pmc.ncbi.nlm.nih.gov/articles/PMC11312525/]
• 32. Protocol for high-quality RNA sequencing, cell surface ... [https://pubmed.ncbi.nlm.nih.gov/40408252/]
• 33. Atlas of Subcellular RNA Localization Revealed by APEX-seq [https://pmc.ncbi.nlm.nih.gov/articles/PMC6786773/]
• 34. Halo-seq: an RNA proximity labeling method ... [https://pmc.ncbi.nlm.nih.gov/articles/PMC9097300/]
• 35. 临近标记复合物、临近标记方法、分子间互作分析方法 [https://patents.google.com/patent/WO2023024066A1/zh]
• 36. Atlas of Subcellular RNA Localization Revealed by APEX ... [https://www.omicsdi.org/dataset/geo/GSE116008]
• 37. A proximity-labeling-based approach to directly detect ... [https://www.sciencedirect.com/science/article/pii/S2162253125001568]
• 38. System-wide analysis of RNA and protein subcellular ... [https://www.nature.com/articles/s41592-023-02101-9]
• 39. RNA fluorescence in situ hybridization for high-content ... [https://www.sciencedirect.com/science/article/abs/pii/S1046202316304212]
• 40. Single-molecule Fluorescence in situ Hybridization ... [https://pmc.ncbi.nlm.nih.gov/articles/PMC8342053/]
• 41. Protocol: Immunofluorescence Staining of Cells for ... [https://biotium.com/tech-tips-protocols/protocol-immunofluorescence-staining-of-cells-for-microscopy/]
• 42. FISH-Flow, a protocol for the concurrent detection of mRNA ... [https://pmc.ncbi.nlm.nih.gov/articles/PMC5548662/]
• 43. Using Single Molecule mRNA Fluorescent in Situ ... [https://www.nature.com/articles/s41598-018-26345-0]
• 44. Automated Image Analysis for Quantitative Fluorescence In ... [https://pmc.ncbi.nlm.nih.gov/articles/PMC1892889/]
• 45. Overview of Common FISH Techniques [https://www.creative-bioarray.com/support/overview-of-common-fish-techniques.htm]
• 46. RNA-associated glycoconjugates highlight potential ... [https://www.nature.com/articles/s12276-025-01585-z]
• 47. Antisense Oligonucleotides: An Emerging Area in Drug Discovery and Development - PMC [https://pmc.ncbi.nlm.nih.gov/articles/PMC7355792/]
• 48. Antisense oligonucleotides: a novel Frontier in pharmacological strategy - PMC [https://pmc.ncbi.nlm.nih.gov/articles/PMC10690781/]
• 49. Advances in RNA-based therapeutics: current breakthroughs ... [https://pmc.ncbi.nlm.nih.gov/articles/PMC12592931/]
• 50. Surfaceome interrogation using an RNA-seq approach ... [https://www.nature.com/articles/s41598-019-42214-w]
• 51. Antisense oligonucleotide therapy - Latest research and news | Nature [https://www.nature.com/subjects/antisense-oligonucleotide-therapy]
• 52. Discovery of RNA‐Targeting Small Molecules - PubMed Central [https://pmc.ncbi.nlm.nih.gov/articles/PMC12375692/]
• 53. Mapping the nanoscale organization of the human cell surface ... [https://pmc.ncbi.nlm.nih.gov/articles/PMC11870420/]
• 54. RNA localization mechanisms transcend cell morphology [https://pmc.ncbi.nlm.nih.gov/articles/PMC9984196/]
• 55. Lost in Translation: Detection of mRNA by Flow Cytometry - Blog [https://blog.td2inc.com/lost-in-translation-detection-of-mrna-by-flow-cytometry]
• 56. Decoding subcellular RNA localization one molecule at a time [https://genomebiology.biomedcentral.com/articles/10.1186/s13059-025-03507-8]
• 57. RNA-binding proteins and glycoRNAs form domains on the cell surface for cell-penetrating peptide entry - ScienceDirect [https://www.sciencedirect.com/science/article/abs/pii/S0092867425001096]
• 58. Selectively expressed RNA molecules as a versatile tool for functionalized cell targeting | Nature Communications [https://www.nature.com/articles/s41467-024-55547-6]
• 59. A large-scale binding and functional map of human RNA- ... [https://www.nature.com/articles/s41586-020-2077-3]
• 60. Cell surface RNA biology: new roles for RNA binding proteins [https://pubmed.ncbi.nlm.nih.gov/40157881/]
• 61. Quantitative Single-Molecule RNA-FISH Probe Design ... [https://pubmed.ncbi.nlm.nih.gov/40894740/]
• 62. Design of a Novel DNA-FISH Probe for the Rapid ... [https://www.mdpi.com/2079-9284/12/3/115]
• 63. FISH-quant v2: a scalable and modular tool for smFISH image ... [https://pmc.ncbi.nlm.nih.gov/articles/PMC9074904/]
• 64. QuantISH: RNA in situ hybridization image analysis ... [https://www.nature.com/articles/s41374-022-00743-5]
• 65. A high-throughput DNA FISH protocol to visualize genome ... [https://pmc.ncbi.nlm.nih.gov/articles/PMC8377592/]
• 66. Single Molecule FISH (smFISH) Imaging [https://www.bruker.com/en/products-and-solutions/fluorescence-microscopy/super-resolution-microscopes/single-molecule-fish-smfish-rna-visualization-and-quantification.html]
• 67. Bridging molecular and cellular neuroscience with proximity ... [https://pmc.ncbi.nlm.nih.gov/articles/PMC12322126/]
• 68. Single-cell RNA-sequencing of peripheral blood ... [https://www.nature.com/articles/s41467-022-30893-5]
• 69. Neuronal RNA Granules: A Link between RNA Localization ... [https://www.sciencedirect.com/science/article/pii/S0896627301005086]
• 70. Massively parallel identification of mRNA localization ... [https://www.nature.com/articles/s41593-022-01243-x]
• 71. Subcellular spatial transcriptomics identifies three ... [https://www.nature.com/articles/s41467-022-34004-2]
• 72. Systematic discovery of subcellular RNA patterns in the gut ... [https://genomebiology.biomedcentral.com/articles/10.1186/s13059-025-03786-1]
• 73. Control of epithelial tissue organization by mRNA localization [https://www.nature.com/articles/s41467-025-60532-8]
• 74. Natural display of nuclear-encoded RNA on the cell surface ... [https://pmc.ncbi.nlm.nih.gov/articles/PMC7488101/]
• 75. FNDC3B promotes cell migration and tumor metastasis in ... [https://pmc.ncbi.nlm.nih.gov/articles/PMC5226524/]
• 76. FNDC3B Gene [https://maayanlab.cloud/Harmonizome/gene/FNDC3B]
• 77. Identification of fibronectin type III domain containing 3B as a ... [https://eurjmedres.biomedcentral.com/articles/10.1186/s40001-024-01823-6]
• 78. Integrated machine learning methods identify FNDC3B as a ... [https://pmc.ncbi.nlm.nih.gov/articles/PMC9582524/]
• 79. Cathepsin S Knockdown Suppresses Endothelial ... [https://pmc.ncbi.nlm.nih.gov/articles/PMC10049538/]
• 80. Cathepsin S (CTSS) activity in health and disease [https://www.sciencedirect.com/science/article/pii/S0098299722000516]
• 81. FNDC3B is associated with ER stress and poor prognosis ... [https://www.spandidos-publications.com/10.3892/ol.2019.11098]
• 82. New Study Reveals How RNA Travels Between Cells to ... [https://cmns.umd.edu/news-events/news/new-study-reveals-how-rna-travels-between-cells-control-genes-across-generations]
• 83. Three Drug Discovery Frontiers Worth Your Attention in Q3 ... [https://axial.acs.org/medicinal-chemistry/three-drug-discovery-frontiers-worth-your-attention-in-q3-2025]
• 84. Applications of single-cell RNA sequencing in drug discovery ... [https://pmc.ncbi.nlm.nih.gov/articles/PMC10141847/]
• 85. Surface-Enhanced Raman Spectroscopy-Based Detection ... [https://pubmed.ncbi.nlm.nih.gov/37908079/]
• 86. SERS sensing for cancer biomarker: Approaches and ... [https://www.sciencedirect.com/science/article/pii/S2452199X23004140]
• 87. Biomarker discovery [https://bostongene.com/biopharma/biomarker-discovery]